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ABSTRACT
Osteoblastic differentiation was studied in vitro using primary cultures of bone cells 
derived from neonatal mouse calvaria.
Using alkaline phosphatase as a marker, maintenance of the osteoblastic phenotype 
was found to be dependent upon the presence of ascorbic acid. No toxic effect due to 
ascorbic acid was seen. Insulin and dexamethasone were found to stimulate alkaline 
phosphatase expression, the former only in the absence of ascorbic acid. Two growth 
factors, epidermal growth factor and platelet-derived growth factor, were found to inhibit 
alkaline phosphatase expression in the presence of ascorbic acid.
Osteogenesis was most pronounced in cultures supplemented with ascorbic acid. 
The osteoblasts formed multilayers of cells and secreted an organic extracellular matrix 
composed mainly of type I collagen. Matrix vesicles were found among the collagen 
fibres. In the presence of 6 -glycerophosphate, calcium phosphate crystals were deposited 
in discrete patches forming a mineralisation front which progressively engulfed osteoblasts. 
The type of matrix formed and the pattern of mineralisation resembled those of lamellar 
bone.
Insulin at 5000ng/ml stimulated matrix calcification in the absence of ascorbic acid. 
Dexamethasone, EOF and PDGF inhibited calcification. The extent of calcification was 
dependent upon the concentration of 6 -glycerophosphate in the culture medium.
Conditioned medium from osteogenic cultures contained a GM-CSF which was 
secreted constitutively by the osteoblasts. Preliminary experiments with a mesenchymal 
stem cell line, Balb/c 3T3, showed the existence of a factor(s) with mitogenic activity in 
bone cell conditioned medium. No inducer of osteogenic differentiation was found.
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SUMMARY
1. The differentiation of mouse osteoblasts was studied in vitro. Bone formation and the 
expression of alkaline phosphatase were used as markers of the differentiated phenotype.
The effects of osteoblastic products upon haemopoietic and mesenchymal cells were also 
studied.
2. Primary cultures of osteoblasts were established following enzymatic digestion of 
neonatal mouse calvaria with dispase and collagenase. Three similar methods are 
compared.
3. Osteoblasts were found to be most abundant in neonatal mouse calvaria, using the 
expression of alkaline phosphatase as a marker. The periostea and sutures contained few 
osteoblasts. An initial method of sequential digestion of the calvaria revealed an increased 
release of osteoblasts from the bones with increased digestion time.
4. Post-confluent cultures (7 days old) of bone cells produced a strong response to 
parathyroid hormone in terms of cAMP production (140.5 ± 33.2 pmoles/10^ cells). The 
response to calcitonin was negligible (3.1 ±1.2 pmoles/10^ cells).
5. Ascorbic acid is essential for the maintenance of alkaline phosphatase expression, up to 
14 days in culture. In the absence of ascorbic acid there was a general decline in alkaline
Îphosphatase expression with time in culture. There was no observable toxic action |  
resulting from the addition of ascorbic acid. This was possibly due to the creation of 
hypoxic conditions as the cultures formed multilayers of cells.
6 . Following the formation of multilayers, the cultures of osteoblasts developed osteogenic 
nodules. In the presence of 6 -glycerophosphate the nodules mineralised. Transmission 
EM showed the extracellular matrix to be composed mainly of type I collagen. Matrix
vesicles were observed. Initial mineral deposition occurred in discrete patches in close 
association with collagen fibres. In the centre of the nodule, there were cells (osteocytes) 
embedded within the mineralised matrix and separated from this by a thin layer of osteoid.
7. In the absence of ascorbic acid, 6 -glycerophosphate caused a significant increase in 
alkaline phosphatase expression. However, in the presence of ascorbic acid, 6 - 
glycerophosphate caused a significant (but transient) decrease. 6 -glycerophosphate was 
found to be necessary for the mineralisation of osteogenic nodules. The deposition of 
calcium increased in a dose-dependent manner with increasing concentrations of 6 - 
glycerophosphate.
10. Media conditioned by osteogenic cultures were found to contain a factor(s) capable of 
stimulating the formation of colonies by GM-CFC in agar cultures. The activity was 
secreted constitutively and was probably GM-CSF.
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8 . Only in the absence of ascorbic acid, did insulin cause a significant increase in alkaline 
phosphatase expression and matrix calcification with a concomitant decrease in cell 
proliferation. No changes in these parameters were seen in the presence of ascorbic acid. 
However, dexamethasone in the presence of ascorbic acid caused a transient increase in 
alkaline phosphatase expression over the 14 day culture period but was without effect on 
cell numbers. By day 14 the stimulation of alkaline phosphatase was no longer apparent 
and cell proliferation and the extent of calcification were both inhibited. In the absence of 
ascorbic acid, dexamethasone stimulated alkaline phosphatase expression at day 14.
9. In this system, EGF and PEK3F were both found to lack mitogenic activity and to inhibit |
calcification. In the presence of ascorbic acid, both growth factors inhibited alkaline I
phosphatase expression. PDGF slightly stimulated alkaline phosphatase in the absence of 
ascorbic acid.
11. Experiments with the mesenchymal stem cell line, Balb/c 3T3 clone A31, failed to 
produce any evidence for osteogenic potential. Culture of the cell line with media 
conditioned by osteogenic primary bone cells elicited a proliferative response, as opposed 
to one inducing differentiation.
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A. INTRODUCTION
The differentiation of bone cells in vitro is characterised ultimately by the ability to 
form bone in a controlled manner. This study was undertaken to establish osteogenic 
cultures in vitro and to determine the influence of various factors upon bone 
differentiation, namely: ascorbic acid, organic phosphate, insulin, dexamethasone (a 
glucocorticoid) and growth factors. Since in vivo bone does not exist as an isolated tissue 
it was also of interest to study the interplay between bone cells and haemopoietic and 
pluripotent mesenchymal cells.
B. STRUCTURE OF BONE
The two main components of bone are the cellular compartment and the extracellular 
matrix. Bone is continuously being turned over; matrix is first resorbed by osteoclasts and 
then replaced by osteoblasts. This dynamic nature is coupled with a highly organised 
architecture indicating the existence of a complex regulatory mechanism. Bone tissue is 
responsive to systemic and local factors as well as mechanical stress and as such presents a 
very complicated model to study.
1. Cells of bone
There are two main cell types associated with bone, osteoblasts and osteoclasts. 
The sequential activity of these cells results in the steady and orchestrated turnover of the 
matrix while the terminal differentiation of osteoblasts (to osteocytes) provides an intricate 
cellular network within the bone matrix.
i) Osteoblasts
a) In vivo
The osteoblast is a polarised, cuboidal cell positioned on the matrix surface and is 
actively involved in the synthesis of matrix proteins and their subsequent uni-directional 
secretion onto the matrix surface (Rodan and Rodan, 1984). This cellular activity is 
reflected in the type of organelles found in the cytoplasm; abundant rough endoplasmic
reticulum for protein synthesis and a Golgi complex for protein packaging and secretion. 
Osteoblastic protein products include type I collagen, alkaline phosphatase, osteocalcin and 
osteonectin (Martin et al.y 1988).
Osteoblasts are found towards the end of a lineage derived from a stem cell which is 
part of the stromal compartment of bone marrow (Friedenstein et aL, 1987). Cells derived 
from colonies of bone marrow fibroblasts in vitro are capable of forming bone and 
cartilage following implantation in vivo in diffusion chambers, however, this has proved 
unrepeatable with similar cultures of human bone and marrow cells (Ashton et at., 1985). 
Uncloned spleen stromal fibroblasts transplanted in diffusion chambers following culture in 
vitro will not normally form bone, the tissue formed being alkaline phosphatase negative 
and consisting of fibroblasts surrounded by collagen fibres (Friedenstein et al., 1970). 
Stromal cells with spontaneous osteogenic ability are therefore to be found in marrow 
stroma, and not in stroma of non-marrow organs.
Having stated that non-marrow stromal cells are incapable of spontaneous 
osteogenesis, it should be noted that these cells can be induced to differentiate along the 
osteogenic pathway (Friedenstein et al., 1970). Potent inductive stimuli have been found 
to be,
i) transitional epithelium, and
ii) decalcified bone matrix.
Osteogenic differentiation is maintained only in the continuing presence of the 
inducer and the stromal cells involved are referred to as Inducible Osteogenic Precursor 
Cells (lOPCs). lOPCs may also be found in marrow (Owen, 1980; Harada et al., 1988). 
Marrow stromal cells following osteogenic differentiation need no such inducer and are 
consequently known as Determined Osteogenic Precursor Cells (DOPCs). Stem cells are 
undifferentiated cells of high mitotic potential that function as the source of lineages of 
differentiated cells resulting in the end cells, highly specialised terminally differentiated 
cells usually incapable of further division (Figure 1). DOPCs have the characteristics of 
stem cells; self-replication and the production of differentiated cells (Vaughan, 1981).
Stem cell -----> committed ---- > differentiated
progenitors end cells
Figure 1. Lineage diagram, showing the progression by proliferation and differentiation from a few, undifferentiated stem cells to the much larger population of terminally differentiated end cells.
Transplantation of marrow fragments results in osteogenesis at the new site 
followed by infiltration by haemopoietic cells of host origin (Friedenstein, 1976). The type 
of haemopoietic tissue formed is dependent upon the source of the transplant, ie red or 
yellow marrow (Patt et al., 1982). Osteogenesis occurs in a similar manner, regardless of 
the marrow origin so the haemopoietic regulation is transferred by a set of marrow stromal 
cells. Retransplantation of the marrow component of the graft results in the formation of 
new osteogenic tissue. However, the number of possible retransplantations is very limited. 
There is therefore some particular element in bone marrow stroma that is capable of 
osteogenesis which is not found in the stroma of other organs. This indicates a finite 
ability of the stromal cells to self-maintain in an obvious absence of replenishment by host 
haemopoietic cells. Marrow transplanted from male to female mice survives and forms a 
new organ composed ostensibly of donor stroma and host marrow. Retransplantation of 
this organ to a secondary female host pre-immunised against male antigens results in 
resorption of the graft. If the transplant in the prirnary host had been repopulated with any 
host (female) stroma cells then the organ would survive transplantation to the secondary 
host (female). However, this does not happen and consequently all the stroma cells are 
male and therefore rejected by the pre-immunised secondary host (Friedenstein and 
Kuralesova, 1971). Therefore, despite the close structural and functional interplay between 
the osteogenic and haemopoietic compartments in vivo, the two lineages appear to self- 
maintain independently in the adult animal.
In correlation with the lineages of the haemopoietic system it has been suggested 
that the osteogenic system is composed of equivalent populations of stem cells, committed
progenitors and differentiating end cells (Owen, 1985). It is proposed that there is a 
pluripotent stromal stem cell capable of giving rise to committed progenitors for reticular, 
fibroblastic, adipocytic and osteogenic lineages (Owen and Ashton, 1986). Similar 
specialised stromal stem cells may exist in other systems (Figure 2). Following 
proliferation, the osteoprogenitor gives rise to the preosteoblast, an alkaline phosphatase 
positive, fibroblastic cell still capable of mitosis (Owen, 1980). The preosteoblast is the 
immediate precursor to the osteoblast, which has very little, if any, mitotic potential.
stromal stem cell
osteoprogenitors
prechondroblast 
chondroblast 4-------
4 ?chondrocyte 4-------
hypertrophied
chondrocyte
preosteoblast
osteoblast 4-----► bonej  lining-► osteocyte cell
other stromal progenitors
adipocyte fibroblast reticular cell endothelial cell
Figure 2. Lineage diagram showing the inter-relationships of the various members of the 
stromal compartment associated with marrow (after Marks and Popoff, 1988; Martin et ai, 1988).
A cell type possibly within the osteogenic lineage is the bone lining cell. This is a 
flattened cell directly apposed to the inactive bone surfaces which form a relatively large 
proportion of the total bone surface area (Miller and Jee, 1987). The cytoplasm is very 
thinly spread over the bone surface and contains a nucleus that is also very thin and is 
surrounded by those few organelles that are present; endoplasmic reticulum, free ribosomes 
and mitochondria (Miller et al., 1980). Several functions have been attributed to bone
lining cells. They form a cellular membrane physically separating the bone fluids from the 
interstitial fluids and could therefore contribute to the regulation of mineral homeostasis by 
maintaining and regulating ion gradients (Bushinsky et al,, 1989). The bone lining cells 
form gap junctions between each other and also with osteocytes, raising the possibility of 
the existence of a 'functional syncytium' composed of bone lining cells and osteocytes; this 
may support the metabolism of osteocytes within the matrix. The bone lining cell may also 
be involved in the initiation of remodeling by;
i) attracting osteoclast precursors,
ii) retracting and therefore exposing the bone surface, and
iii) removing osteoid, ie the covering layer of unmineralised bone matrix.
It is also believed that the bone lining cell may represent an inactive osteoblast (Peck 
and Woods, 1988).
Osteocytes are the end cells of the osteogenic lineage. They lie within lacunae and 
are completely surrounded by the extracellular matrix. Both in vivo and in vitro 
osteocytes assume a stellate morphology by extending cytoplasmic processes. In vivo 
these protrude into canaliculi (Nijweide and Mulder, 1986). The osteocyte may contribute 
to mineral homeostasis by selective action (resorption and deposition) of the perilacunar 
bone (Chambers, 1980; Martin et al., 1988). Due to the proximity of the osteocyte 
network with the bone mass, these cells may act as go-betweens, translating changes in 
bone stress to messages for osteoblast or osteoclast activation. Indeed the osteocyte may 
encourage osteoclastic resorption by secreting enzymes thus causing osteocytic osteolysis. 
This is seen during bone growth and also during pathological states, eg severe calcium 
deficiency (Chambers, 1980). In actively growing rabbit bone there is a fixed lifetime for 
the osteoblast while it is apposed to the bone surface and secreting matrix before it is 
embedded in the matrix and becomes an osteocyte (Owen, 1963). The transition stage 
between osteoblast and osteocyte in embryonic chick bone has been termed the osteoid-
osteocyte (Palumbo, 1986). This cell type is still capable of synthesising matrix proteins 
and is completely surrounded by osteoid.
b) In vitro
The heterogeneity of bone tissue poses problems concerning the interpretation of 
results. A method to simplify any system is to break it down into its component parts and 
to examine these individually. The culture of osteoblastic cells can be used to answer 
questions concerning, for example, the regulation and mechanisms of osteoblastic 
behaviour. The results from such studies, however, may not bear a direct correlation with 
the in vivo situation, although they will be an approximation and will aid the interpretation 
of in vivo data.
In vitro, osteoblasts can be studied in organ culture, primary cell culture or as a 
clonal cell line. The simplest technique used to study bone tissue in vitro has been organ 
culture and the most common tissue source used is fetal rat calvaria, due to the large size 
and accessibility of these bones. Fetal rat tibiae have also been used (Stracke et al., 1984). 
Calvaria are dissected out from fetal rats and then split along the saggital suture to give two 
segments each consisting of a frontal and parietal bone (Figure 3) (Dietrich et al., 1976). 
The calvarial halves are then incubated in liquid medium for up to 48 hours at 37°C. This 
method is also successful if neonatal rats are used as the source of calvarial tissue (Jones 
and Boyde, 1976). Organ culture need not necessarily be of the whole bone. Portions of 
calvaria can be excised in a punch biopsy and then cultured. A segment 5 to 8 mm in 
diameter is taken from the the frontal calvarial bones of neonatal rats and then incubated in 
liquid medium at 37°C (Hahn et al., 1984; Ituarte et al., 1988).
ROSTRAL
Frontal BoneCoronal Suture
Saggital Suture Parietal Bone
Anterior Lamboidal 
Suture
Interpaiietal Bone
CAUDAL
Figure 3. Diagram describing the anatomy of the calvarial plates.
The use of organ culture provides a system which maintains the inter-cell spatial 
arrangements and contacts and as such is very like the in vivo situation. However, these 
methods provide scant information concerning the function and responses of individual cell 
types. To do this it is necessary to isolate the bone cell types and study cultures derived 
from purified cell fractions. There are various methods for doing this and they can be 
broadly divided into mechanical and enzymatic.
An early mechanical method involved cell dispersal from adult rat calvaria by 
shaking for 45 minutes in phosphate buffer (Smith et al., 1973). Osteoblasts have also 
been isolated by using their ability to migrate (Jones and Boyde, 1977). Fragments of 
parietal bone from 2 week old rats were incubated in contact with glass spicules for up to 5 
days, during which time cells migrated from the bone onto the glass. This method was 
later refined, using more immature cells from periosteum-free neonatal mouse calvaria and 
allowing the cells to migrate directly onto the Petri dish surface (Zambonin Zallone and 
Teti, 1984). The cells growing out from the fragments are alkaline phosphatase positive, 
indicating the osteogenic nature of the migratory cells (Takahashi et al., 1986). Cultures 
established by calvarial outgrowth are slow to produce a high cell yield and may even need
8
to be passaged before being used, which could result in non-mitotic osteoblasts being over­
run by more prolific cell types, eg fibroblasts.
Enzymatic isolation techniques produce a high yield of primary cells and can be 
used to establish cultures derived from cell populations with different properties eg 
response to parathyroid hormone and calcitonin. Peck and colleagues (1964) prepared a 
single cell suspension of bone cells by incubating fetal and neonatal rat calvaria with 
collagenase. All the cells released exhibited detectable alkaline phosphatase and half 
showed intense cytoplasmic reaction. Other enzymes were also tried but these caused 
either too much cell damage (pronase) or released too few cells (trypsin). Another early 
attempt to isolate bone cells used a cocktail of enzymes (Hekkelman and Moskalewski, 
1969). Collagenase, trypsin and DNA-ase dissolved in phosphate buffered saline were 
found to release alkaline phosphatase positive cells from fetal rat calvaria. Tryspin alone 
has also been used on periosteum-free fetal rat calvaria (Binderman et al., 1974). Alkaline 
phosphatase activity was found in the bone cells isolated, and cultures established with 
these cells produced a calcified extracellular matrix.
A major step forward in the production of bone cell suspensions was the 
development of sequential digestion by Wong and Cohn (1974). They digested neonatal 
mouse calvaria with an enzyme solution of trypsin and collagenase for a total of one hour. 
However, at twenty minute intervals the enzymes were aspirated and replaced with fresh 
solution. This method produced three different aspirates, each containing a different 
population of bone cells. These populations were then characterised in terms of cAMP 
response to parathyroid hormone and/or calcitonin. The last population was the most 
responsive and also exhibited an additive effect of the hormones, thus showing;
i) the existence of a sub-population of bone cells acting as a target for parathyroid 
hormone and calcitonin, and also
ii) the possibility of two cell types within this sub-population with different hormonal 
responses.
Cultures established following five digestions showed the early populations ( 2  and 
3) to respond to calcitonin and the late populations (3, 4 and 5) to respond to parathyroid 
hormone (Wong and Cohn, 1975). Populations of bone cells with different properties can 
therefore be isolated from bone using sequential digestion.
The methodology of sequential digestion has the advantage of producing 
functionally different bone cell populations. However, large numbers (> 50) of calvaria are 
required to achieve a good cell yield (Boonekamp et a i, 1981). Careful dissection of the 
bones before digestion can greatly reduce contamination by non-osteoblastic cells. Yagiela 
and Woodbury (1977) dissected out the frontal and parietal bones of fetal and neonatal 
rats, ensuring that the bone segments were free of both suture tissue and immature bone. 
The periosteum was then peeled off the bones and the fragments incubated with 
Worthington collagenase class II for two hours. They found that the highest numbers of 
osteoblastic cells (as judged by morphological criteria) were present in the 18 to 19 day old 
rat fetus. Cells with osteoblastic properties can also be isolated from fetal chick calvaria 
using a similar method (Nijweide et al., 1981).
Contamination by non-osteoblastic cell types can be avoided, not only by careful 
dissection, but also by discarding the supernatant of early digests (Heath et a i, 1984). 
Neonatal mouse calvaria were stripped of periostea and sutures and then incubated with 
trypsin (10 minutes) and dispase (30 minutes). The cell suspensions produced were 
discarded and a final two incubations with Worthington collagenase class II (30 minutes 
each) were pooled. The cell population was enriched for osteoblasts, as assessed by 
alkaline phosphatase content, collagen type I synthesis and cAMP response to parathyroid 
hormone.
It is possible, therefore, to establish cultures of osteoblastic cells from the relatively 
heterogeneous tissue source of fetal and neonatal bone. To purify further osteoblastic 
cultures it is possible to produce cloned cell lines; at least two such exist. ROS cell lines 
were established by digesting minced rat osteosarcoma tissue with hyaluronidase and 
collagenase for 20 minutes (Majeska et ah, 1978). Trypsinised cultures were diluted and 
seeded into multiwell plates to encourage clonal development. The ROS lines exhibited a
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pronounced cAMP response to parathyroid hormone and no response to calcitonin and they 
also retained an osteogenic ability, forming osteogenic tumours following transplantation in 
vivo. MC3T3 lines were established from neonatal mouse calvaria (Kodama et al., 1981). 
Primary cultures were produced by allowing cellular outgrowth from periosteum-free bone 
fragments in vitro. The cells were passaged using trypsin and selection of a suitable clone, 
MC3T3-E1, was based upon alkaline phosphatase activity.
ii) Osteoclasts 
a) In vivo
The osteoclast is a large multinucleated cell found associated with bone surfaces and 
it is the major cell type involved in bone resorption (Marks and Popoff, 1988). The cell 
membrane of the active osteoclast in contact with the bone is divided into two functional 
areas. The inner, central area of the membrane forms a ruffled border and is the site of 
secretion of enzymes. The extracellular space bounded by the ruffled membrane is also 
acidified due to the catalytic action of carbonic anhydrase on metabolic products (Hall and 
Kenny, 1986);
CO2 + H2 O ">  H+ + HCO3
The outer ring of membrane is flattened and is in close contact with the bone surface 
to form a clear zone functioning as a tight lateral seal limiting the area of bone resorption 
and thus allowing the formation of a microenvironment suitable for osteolysis (Sakamoto 
and Sakamoto, 1986). Inactive osteoclasts are not in contact with the bone surface and are 
kept away by the covering of osteoblasts and bone lining cells (Sterrett, 1986). Inactive 
osteoclasts do not possess a ruffled membrane.
Osteoclasts are possibly the end cell derived from a stem cell located in the marrow. 
However, it was once believed that the osteoclast was intimately connected with the 
osteogenic lineage (Hall, 1975). Evidence for this was seen in the co-ordinated decrease in 
osteoclasts and increase in osteoblasts and preosteoblasts in vivo following administration 
of calcitonin. This does not, however, prove that the former can develop into the latter. It 
is possible, however, that multinucleated osteoclasts are formed by the fusion of a variety
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of cell types; local mononucleated preosteoclasts, osteocytes, preosteoblasts and blood- 
borne cells (Hanaoka et al., 1989).
The distinctness of osteoclasts from the osteogenic lineage has been shown by 
studying the quail nuclear marker during endochondral ossification (Kahn and Simmons, 
1975; Jotereau and Le Douarin, 1978). On the basis that chick chromatin is evenly 
distributed and quail chromatin is found in clumps it is possible to follow cell lineages in 
chimeric bones. Transplantation of quail limb bud onto chick embryo chorio-allantoic 
membrane resulted in endochondral ossification of the transplanted tissue and the formation 
of a bone organ with associated marrow. All the stroma cells were of donor (quail) origin 
and all the haemopoietic cells of host (chick) origin. It was also found that none of the 
osteoclasts exhibited quail chromatin, ie they were of host origin, indicating a blood borne 
(as opposed to osteal) and therefore haemopoietic derivation. Transplantation from chick to 
quail produced similar results, though not as conclusively as only two thirds of quail cells 
possess clumped chromatin.
The preosteoclast is a mononuclear precursor with the morphology of a 
mononuclear leukocyte (Bonucci, 1981). Osteoclasts have been shown to develop in 
initially osteoclast-free explants of fetal mouse calvaria following co-culture with 
previously cultured mononuclear cells from adult marrow (Ko and Bernard, 1981). 
Osteoclasts were not found in control cultures, showing that the osteoclastic precursors 
were amongst the mononuclear population.
The mononuclear nature of preosteoclasts has also been shown by using 
monoclonal antibodies raised against cells of the monocyte-macrophage lineage (Sminia 
and Dijkstra, 1986). In fetal rats specific antibody-positive cells were found in the 
perichondrium and were mononucleate and acid phosphatase positive. The expression of 
acid phosphatase is characteristic of the osteoclastic phenotype (Bonucci, 1981). The 
antibody positive cells then infiltrated the developing bone and multinucleated antibody 
positive cells were also seen within the marrow cavity. As the antibody reacts with 
antigens found solely on mononuclear phagocytes, the multinucleated acid phosphatase 
positive cells associated with the developing bone are also members of this series.
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As has been seen, the haemopoietic and osteogenic lineages in the adult animal self- 
maintain independently (Friedenstein and Kuralesova, 1971). Therefore the osteoclast is 
ultimately derived from a haemopoietic stem cell (Schneider et al., 1986). 
Developmentally, osteoclast stem cells and/or progenitors migrate from the yolk sac and are 
initially widely disseminated throughout the fetus (Thesingh, 1986).
The major role of the osteoclast is bone resorption. In vivo, resorption is followed 
by bone formation and the two complementary processes are coupled together to maintain a 
steady bone mass, despite variable turnover. This mechanism is referred to as coupling 
and it occurs during bone remodeling (Peck and Woods, 1988).
The remodeling cycle is characterised by the orderly progression through the 
sequence;
i) quiescence,
ii) initiation and activation,
iii) resorption,
iv) reversal,
v) formation,
vi) return to quiescence,
(Kahn et al., 1983; Marcus, 1987; Martin et al., 1988; Parfitt, 1988; Peck and Woods, 
1988; Raisz, 1988).
During the quiescent stage the resting bone surface is covered in bone lining cells or 
resting osteoblasts. This is the normal state of the majority of the adult bone surface. 
Protecting the bone is a very thin layer of unmineralised matrix which is a sufficient barrier 
to osteoclastic resorption (Chambers and Fuller, 1985). However, if the surface is 
removed by collagenase digestion then osteoclastic resorption can proceed. Therefore, in 
vivo, the unmineralised matrix must be removed before osteoclast activation occurs. It is 
likely that the cell responsible for this is a member of the osteogenic lineage as pre­
incubation of bone slices with calvarial cells greatly enhances the resorptive ability of 
osteoclasts. It has been shown that osteoblastic cells possess receptors for parathyroid 
hormone and respond to stimulation by this hormone by synthesising and secreting
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collagenase (Heath et al., 1984; Puzas and Brand, 1979; S live et al., 1982). The action of 
parathyroid hormone upon osteogenic cells results in the digestion of the unmineralised 
layer of matrix thus exposing the bone mineral. The release of parathyroid hormone may 
represent an initiation event causing the activation of osteoblasts and the subsequent 
chemotactic response of osteoclasts, possibly to the exposed bone mineral (Osdoby et al., 
1987). Monocytes can respond chemotactically to bone proteins (osteocalcin, a2 HS 
glycoprotein and collagen type I) (Malone et al., 1982). Not only do hormones which 
stimulate bone resorption, for example parathyroid hormone and prostaglandin E^, 
promote collagenase release, they also cause shape changes in osteoblastic cells, thus 
uncovering the matrix (Rodan and Martin, 1981). Osteoblasts may also play an important 
role in the differentiation of mononucleate osteoclast precursors by fusion to form 
functional osteoclasts (Takahashi et a l, 1988).
Following the activation phase of remodeling the bone mineral is resorbed by 
osteoclasts, forming Howship's lacunae in trabecular bone. Bone resorption is dependent 
upon osteoclastic acid phosphatase, as inhibition of this enzyme by specific antibodies 
results in the loss of resorption (Zaidi et al., 1989). According to the the two cell theory of 
bone resorption more than one cell type is involved in the removal of matrix (Heersche, 
1978; Sterrett, 1986). Osteoclasts déminéralisé and then degrade the non-collagenous 
matrix, but the removal of collagen fibrils may be the function of mononuclear phagocytes. 
This was proposed to explain the absence of collagen fibres within osteoclasts. However, 
this could also be explained by the hypothetical existence of collagen as a collagen- 
collagenase-collagenase inhibitor complex. Inactivation of the inhibitor by osteoclastic 
action would allow the degradation of collagen by collagenase in the extracellular space, 
rather than by breakdown in the osteoclast cytoplasm (Sakamoto and Sakamoto, 1986). In 
support of this, osteoclastic degradation of collagen has been shown to be independent of 
the secretion of collagenase (Blair et al., 1986). The control of osteoclastic resorption 
during steady state turnover is unknown but it continues over a period of one to three 
weeks to a mean depth of 50^m. Osteoclasts are then replaced by mononuclear cells, 
possibly of the monocyte-macrophage lineage, which smooth over the surface of the pit,
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possibly by removing the exposed collagen fibres. These cells may also deposit the cement 
line, demarcating the furthest extent of resorption. The stage between the end of resorption 
and the beginning of bone formation is known as reversal and may last for one to two 
weeks.
Bone formation is initiated by the recruitment of osteoblasts and the subsequent 
secretion of matrix. Osteoblasts in vitro respond chemotactically to a protein component of 
bone matrix (Somerman et al., 1983). Resorbing bone is also a good source of mitogenic 
activity which may act on osteoprogenitor cells to produce an increase in osteoblast number 
(Farley et al., 1987). The attraction of osteoblasts to the site of bone remodeling may 
therefore be controlled by the release of chemoattractants and mitogens from secondary 
lysosomes of osteoclasts following resorption from the matrix.
Initially, the matrix formed by the osteoblast is unmineralised but as formation 
progresses the matrix calcifies and a mineralisation front forms, above which lies an 
osteoid seam. The most recently formed collagen fibres in the osteoid are disorganised but 
become increasingly aligned due to cross-linking before the matrix is mineralised. As 
formation progresses the osteoblast becomes smaller and there is a probable corresponding 
decrease in the rate of matrix synthesis. Eventually the osteoid seam disappears as the 
mineralisation front advances and the bone surface returns to the quiescent state.
b) In vitro
Osteoclastic behaviour in vitro can be studied in organ culture or as isolated cells in 
primary culture. Organ culture is used to study the mechanisms and control of resorption. 
Typically, rats at day 18 of pregnancy are injected with a radioactive isotope of calcium, 
45Ca (Ibbotson et al., 1986; Raisz and Niemann, 1969). The following day, the fetuses 
are removed and the shafts of the radii and ulnae dissected out and cultured in liquid 
medium for up to five days. The amount of ^^Ca released is used as a measure of bone 
resorption. A similar method involves neonatal mouse calvaria (Reynolds, 1976). The 
mice are prelabelled with 45Ca and then half calvaria are cultured as explants at the 
liquid/gas interface for two days.
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Cultures of isolated osteoclasts can give more information concerning, for instance, 
the specific cellular response to bone hormones. To establish such cultures, the femoral 
and tibial shafts of neonatal rats are split longitudinally and the cut surface is scraped to 
release bone fragments into culture medium (Chambers and Magnus, 1982). The 
fragments are agitated by pipetting to release cells and aliquots of the medium transferred to 
tissue culture grade Petri dishes. Following a 30 minute incubation at 37°C, the dishes are 
washed and the medium replaced. The adherent cells remaining in the Petri dishes are 
predominantly osteoclasts; they are large multinucleated cells with a membranous 'skirt' 
giving a 'fried egg' appearance (Arnett and Dempster, 1986; Chambers and Magnus, 
1982).
The regulation of osteoclastic behaviour is complex and not always direct. Two 
potent stimulators of bone resorption are parathyroid hormone (PTH) and a metabolite of 
vitamin D, 1,25-dihydroxyvitamin D3 (l,25(OH)2D3). In vivo, a drop in blood calcium 
levels stimulates the parathyroid gland to release PTH (Dickson, 1987). The hormone can 
then influence bone resorption via two prominent mechanisms.
PTH can act directly upon bone cells (Chambers et at., 1984). Added to isolated 
osteoclasts, PTH has no discernible effect, however, co-culture of osteoclasts with 
osteoblasts results in increased osteoclastic spreading and bone resorption (McSheehy and 
Chambers, 1986a). PTH stimulates the osteoblastic cells to produce a factor that directly 
affects osteoclasts and stimulates bone resorption (McSheehy and Chambers, 1986b). PTH 
has also been shown to stimulate osteoblastic cells to secrete prostaglandin E (MacDonald 
et al., 1984). Prostaglandins can either inhibit osteoclast motility, or can stimulate the 
release of osteoclast activation factor (OAF) from phytohemaglutin-stimulated lymphocytes 
(Chambers and Ali, 1983; Sterrett, 1986).
Alternatively, PTH can influence the production of l,25(OH)2D3 (Dickson, 1987). 
Vitamin D is converted to 25-hydroxyvitamin D3 in the liver. This metabolite is acted upon 
by a PTH-regulated kidney hydroxylase to produce l,25(OH)2D3. The systemic effect of 
1,25(0H)2D3 is to increase blood calcium levels by;
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i) stimulating the synthesis of calcium-binding protein by the gut and thus calcium 
absorption, and 
Ü) stimulating bone resorption.
In bone, the cellular site of action of l,25(OH)2D3 is very likely to be the 
osteoblast. Two cell lines have been shown to possess cytosolic receptors for 
1,25(0H)2D3 (Partridge et al., 1980; Walters et aL, 1982). The indirect effect of 
1,25(0H)2D3 upon bone resorption may be mediated through osteoblastic cells, in a 
manner similar to that of PTH.
Vitamin D is also, paradoxically, involved in mineralisation (Wong et al., 1977). 
However, there are many metabolites of this vitamin and it is probably the concerted action 
of 1,25(0H)2D3 raising the serum calcium levels (by increased absorption from the 
intestine) with 24,25-dihydroxy vitamin D3  that enhances mineralisation (Ornoy et al., 
1978).
Calcitonin, produced in the thyroid, acts directly via an osteoclastic receptor to 
cause inactivation and inhibition of bone resorption (Nicholson et al., 1986). Exposure of 
isolated osteoclasts to calcitonin results in a decrease in motility and retraction of 
lamellipodia (Chambers and Magnus, 1982). The transformation caused by calcitonin 
occurs at very low concentrations (> 3pg/ml), is reversible and can be prevented by pre­
incubation with trypsin (Chambers and Moore, 1983).
In summary, bone is very much a live tissue exhibiting continual and controlled 
turnover of the extracellular matrix by osteoclasts and osteoblasts. Terminal differentiation 
of osteoblasts to osteocytes may play an important role in calcium homeostasis, as may 
hormonal control of resorption. The two main cell types associated with bone are 
osteoblasts and osteoclasts and these are derived from stem cells, respectively stromal and 
haemopoietic, and these are located within the marrow cavity.
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2. The extracellular matrix
The extracellular matrix of bone consists of a mineralised framework mainly of type 
I collagen, and some non-collagenous proteins. The organic component is synthesised and 
secreted largely by osteoblasts but it does contain some plasma-derived proteins. The 
matrix is mineralised by the deposition of hydroxy apatite (a form of calcium phosphate). 
The non-collagenous proteins are probably involved in the general maintenance and 
regulation of the matrix secretion and mineralisation (Table 1.)
Molecule Mass Amount Origin Known ( and possible) roles
Collagen 90%2 osteoblasts structural^ (mitogen®)
Osteonectin 32kD" 2.5%9 osteoblasts collagen-apatite bridge2  mineralisation regulator^ 
(cell-substrate bridge^®)
a 2HS-glycoprotein 50kDi2 2.5%2.9 liver cells ^ 2 binds to mineraP2  (role in resorption^2 )
Osteocalcin 6 kDi2 2 .0 % 2 osteoblasts ^ 2 chemoattractant for osteogenic cells binds mineral^
Proteoglycans 78kD-120kD2.3
1 .0 % 2 7 (aid collagen fibrilassembly42)
Bone
sialoprotein
23kDi2 0 .8 -
1 .2 %i2 ? cell adhesion^ binds to calcium^^
Table 1. Summary of the main molecules associated with the bone matrix
1. D oiera/., 1989
2. Gehron Robey et al., 1988
3. Goldberg era/., 19884. Lucas et al., 19885. Oldberg et a l, 1986
6 . Piez, 19871. Price, 1983
8 . Rath and Reddi, 19799. Rodan and Rodan, 1984
10. Stenner et a l, 198611. Termine et a l, 198112. Triffitt, 198713. Vaughan, 1984
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i) The organic extracellular matrix
a) Collagen
Type I collagen is the major constituent of bone matrix, of which it comprises 
roughly 90% of the organic part (Rodan and Rodan, 1984). Collagen is formed from three 
collagenous propeptide chains wound round each other to produce a triple helix structure 
(Gehron Robey et al., 1988). The polypeptide chains of type I collagen are two a  1(1) 
chains and one a2(I) chain. There are at least ten different collagen types whose functions 
are predominantly structural (Piez, 1987). It may also act as a local mitogen (Rath and 
Reddi, 1979).
Triple helical procollagen is released from secretory vesicles into the extracellular 
space where the molecule is converted to collagen by the enzymatic removal of the amino- 
and carboxyl-terminal propeptides. The collagen molecules are then arranged into bundles 
to form collagen fibrils which are characterised by a regular banding pattern. Cross-linking 
then occurs between the fibrils to produce a very stable structure and to protect the molecule 
from degradation (Laurent, 1987). Nevertheless, collagen molecules undergo degradation 
both intra- and extracellularly, possibly to preserve collagen homeostasis.
The secretion of normal collagen is dependent upon the presence of ascorbic acid 
(de Clerck and Jones, 1980). It is necessary for the normal synthesis of hydroxyproline 
(which stabilises the helical structure) and hydroxylysine (which forms the cross-links) 
(Murad et al., 1981). Ascorbic acid functions as a co-factor in the hydroxylation of prolyl 
and lysyl residues (Pinnell et al., 1987). Ascorbic acid has also been shown to cause an 
increase in the levels of mRNA for the procollagen polypeptide chains.
Collagen fibrils within adult cortical bone assume a very organised architecture 
(Giraud-Guille, 1988). The arrangement can resemble either 'twisted plywood' or 
'orthogonal plywood'. The collagen fibrils of orthogonal plywood form distinct layers, 
each lying at right angles to those adjacent, forming orientated collagen sheets. Twisted 
plywood structure appears as a series of nested arcs producing a scalloped pattern. It is
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likely that the development of the fibril orientation is controlled by osteoblasts (Jones and 
Boyde, 1976).
b) Glycoproteins
The bone matrix contains several different glycoproteins. Bone sialoprotein 
accounts for 8 % to 12% of the non-collagenous protein (Triffitt, 1987). Bone sialoprotein 
contains roughly 20% sialic acid (Butler, 1987). Two other proteins, sialoprotein I and 
sialoprotein n, contain 5% and 13% sialic acid respectively. Sialoprotein I (or osteopontin) 
and sialoprotein II share sequences with fibronectin and vitronectin and can cause the 
adhesion and spreading of ROS cells (Oldberg et al., 1986; Oldberg et al., 1988b). 
Indeed, the receptor for osteopontin is identical to that for vitronectin, Sialoprotein mRNA 
is found in bone, but not in ROS cells, suggesting that osteoblasts may not necessarily be 
the source of this glycoprotein (Oldberg et al., 1988a). Despite the marked presence of 
sialoproteins within the bone matrix, their function is unknown. Apart from the cell- 
binding regions they exhibit strong calcium binding properties and may act as organic- 
inorganic bridges (Vaughan, 1984).
In fetal calf bone, approximately 25% of the non-collagenous protein is osteonectin 
(Rodan and Rodan, 1984). The abundance of this glycoprotein indicates an important 
bone-related function. Osteonectin has been found to contain covalently bound phosphate 
groups and to possess binding sites for collagen and hydroxyapatite. It may act as a bridge 
between these two matrix components, possibly functioning as a nucleator of 
mineralisation (Termineera/., 1981; Termine, 1983; Triffitt, 1987). Although osteonectin 
has been shown to enhance apatite binding to collagen at 25°C, it inhibits the formation of 
hydroxyapatite crystals at 37°C (Doi et al., 1989). Osteonectin may act by preventing 
disorderly precipitation from super-saturated solutions. The distribution of osteonectin is 
limited to mineralising bone trabeculae and consequently it is a tissue-specific protein. 
Immunocytochemistry using polyclonal antibodies raised against osteonectin shows it to be 
a marker of osteogenic differentiation (Jundt et al., 1987). It is found in osteoprogenitor 
cells, osteoblasts and immature osteocytes.
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Osteonectin is synthesised in vitro by osteoblastic cells isolated by enzymatic 
digestion of fetal porcine calvaria. It is also found within platelets and may be released 
during coagulation. This possibility has given rise to the idea that osteonectin may also be
5
1
involved in the adhesion of cells to substrates (Otsuka et al., 1984; Stenner et al., 1986;
Tracy et al., 1988). Osteonectin shows some sequence homology with two glycoproteins |  
not associated with bone, namely a 43K protein and SPARC (secreted protein which is 
acidic and rich in cysteine) (Tracy et al., 1988).
Thrombospondin is an adhesive glycoprotein synthesised by osteoblasts and is 
incorporated into the matrix, although this may not be the sole source of bone 
thrombospondin (Gehron Robey et al., 1989). The molecule is endowed with several 
binding sites for Ca2 + as well as for collagen and has been found to form complexes with 
osteonectin; this may reflect its bone-related function (Clezardin et al., 1988).
c) Gla-containing proteins
Two y-carboxyglutamic acid (Gla)-containing proteins are found in the bone matrix. 
The presence of Gla in clotting factors is important during coagulation (Triffitt, 1987). 
Glutamic acid is converted to Gla by a vitamin K-dependent process.
Bone Gla protein (BGP) or osteocalcin is a highly conserved bone protein which 
accounts for about 20% of non-collagenous protein (Gehron Robey et al., 1988; Groot et 
al., 1986). During induced endochondral osteogenesis the appearance of osteocalcin 
coincides with the calcification of the matrix (Hauschka and Reddi, 1980). It is found in 
the mineralised matrix, but not in the osteoid, although this may be an artifact (Groot et al.,
1986). The function of osteocalcin in vivo is unknown, but it may act as a nucleator of 
mineralisation due to its high affinity for hydroxyapatite and its ability to interact with the 
phospholipids of the matrix vesicle membrane (Gendreau et al., 1989; Price, 1983). 
Osteocalcin also acts as a potent chemoattractant for ROS cells (a cell line derived from a 
rat osteosarcoma), chick limb bud mesenchymal cells and chick embryonic fibroblasts 
(Lucas et al., 1988; Mundy and Poser, 1983). During remodelling osteocalcin will be 
released as the matrix is degraded and may therefore be able to act as a chemoattractant for
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osteogenic cells. It is likely that osteocalcin is synthesised and secreted by a cell belonging 
to the osteogenic lineage. Its production is stimulated by l,2 5 (OH>2 D 3 and inhibited by 
TGFB (Lian et a l,  1985; Noda, 1989; Price, 1983). This response to l,25(OH)2D3 is 
very specific and provides a method to identify osteoblasts in vivo (Gallagher et a l,
1986).
As the synthesis of osteocalcin is dependent upon vitamin K, the function of 
osteocalcin can be studied in animals treated with the vitamin K antagonist, Warfarin 
(Price, 1983). However, Warfarin-treated animals appear to have normally mineralised 
bones, however, although there are some abnormalities associated with the mineralisation 
of cartilaige. These effects are due to the inhibition of synthesis of another Gla-containing 
protein, matrix Gla-protein (MGP) (Price, 1988).
MGP is found within the matrices of bone and cartilage, and in bone it is associated 
with BMP (Triffitt, 1987). It is a larger molecule than osteocalcin but they share 
homologous sequences, suggesting a common genetic ancestor.
d) Proteoglycans
Proteoglycans are characteristically composed of a protein core with 
glycosaminoglycan side chains. In mineralised matrix they constitute roughly 10% of the 
non-collagenous protein (Gehron Robey et a l, 1988). The function of proteoglycans may 
be to aid the assembly of collagen fibrils (Triffitt, 1987). Proteoglycans have been found to 
be localised to the developing bone matrix and osteogenic cells (Termine, 1983).
Bone proteoglycans are small for this class of molecule and consist of a protein core 
(molecular mass 38kD), off which lie either one (PGII, or decorin) or two (PGI, or 
biglycan) chondroitin sulphate chains (40kD each) and several oligosaccharides (Fisher et 
a l,  1989). PGI and PGII are immunologically distinct from each other (Prince, 1987). 
Similar proteoglycans are synthesised by osteoblasts in vitro, however, the chondroitin 
sulphate chains are replaced with dermatan sulphate (Ecarot-Charrier and Broekhuyse,
1987). Keratan sulphate proteoglycan (KSPG) is found in rabbit cortical bone and it has a 
core protein identical to sialoprotein (Kinne and Fisher, 1987). Three hydroxyapatite-
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4associated proteoglycans (HAPGl, 2 and 3) have been recorded (Goldberg et al., 1988). 
HAPGl has a molecular weight of 110 - 120kD and a protein core of 45kD. HAPG2 and 
HAPG3, though distinct, have a total weight of 100 - llOkD and protein cores of 37 - 
38kD.
e) Plasma proteins
The bone matrix contains proteins concentrated from plasma. a 2HS glycoprotein 
accounts for approximately 25% of the non-collagenous protein (Rodan and Rodan, 1984). 
a 2 HS glycoprotein is synthesised in the liver and has a high affinity for bone mineral and 
may play a role in resorption (Triffitt, 1987). Serum albumin is also found in bone 
(Gehron Robey etal., 1988).
f) Growth factors
Growth factors are usually small polypeptides with hormone-like characteristics. 
They function as growth regulators by acting as mitogens (Canalis, 1988; Maclean and 
Hall, 1987). Growth factors associated with the bone matrix may play an important role in 
the coupling of resorption and formation as well as acting as mediators for systemic 
hormones. Growth factors found within the matrix include fibroblast growth factor (both 
acidic and basic), transforming growth factor (6 i and 6 2 ). insulin-like growth factor (I and 
II), bone-derived growth factor, platelet-derived growth factor and skeletal growth factor 
(Table 2) (CanaHs, 1988; Lau etal., 1988).
Transforming growth factor (TGF) can induce the formation of anchorage- 
independent colonies by non-neoplastic cells. There are two classes of TGF; a  and 6 . 
TG Fa acting alone can induce colony formation, and it is not found in bone. TGFB 
induces colony formation in the presence of epidermal growth factor (EGF) and is found in 
three forms; Bi, B2  and B1 .2  (Canalis, 1988). TGFB is probably identical in structure and 
function to cartilage-inducing factor A (Ellingsworth et al., 1986).
Bone TGFB is not a plasma-derived factor, but is synthesised and secreted by 
osteoblastic cells, although TGFBi mRNA is also found in osteoclasts (Gehron Robey et
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al., 1987; Sandberg et al., 1988). During endochondral osteogenesis TGFB is localised 
within the developing mineralised matrix (Carrington et al., 1988). In vitro, TGFB affects 
the differentiation and proliferation of bone cells. Cell growth is inhibited in two cell lines, 
ROS and MC3T3-E1, by TGFB in the range 2 to lOng/ml (Elford et al., 1987b; Noda and 
Rodan, 1986; Noda and Rodan, 1987). However, the phenotypic expression of alkaline 
phosphatase is stimulated in ROS cells and inhibited in MC3T3-E1 cells. Primary bone cell 
cultures show stimulated proliferation and collagen synthesis in response to TGFB and 
inhibition of alkaline phosphatase activity (Centrella e ta l,  1987a; Centrella e ta l,  1987b; 
Rosen e ta l, 1988; Wranaera/., 1988).
TGFB may act as a coupling factor during the cycle of resorption and formation. 
Osteoclasts are capable of synthesising TGFB, which is activated by an acidic environment, 
such as that found associated with the ruffled border of activated osteoclasts. The activated 
TGFB could then act upon osteoblastic cells consequently stimulating both collagen 
synthesis and proliferation in direct relation to osteoclast action.
Bone-derived growth factor (BDGF) is synthesised, though not exclusively, by 
bone cells (Canalis, 1988; Canalis et a l, 1988b). However, to call BDGF a growth factor 
may be a misnomer, as it is 6 2  microglobulin, a small globular peptide associated with a 
major histocompatability complex antigen. Nevertheless, BDGF has been found to 
stimulate collagen and DNA synthesis in bone, as well as to act as a mitogen for fibroblasts 
(Centrella and Canalis, 1985; Canalis and Centrella, 1986). Six other distinct BDGFs have 
been extracted from fetal calf bone (Hauschka et a l, 1986).
Insulin-like growth factor I (IGF I), also known as somatomedin-C, is synthesised 
by bone cells in organ culture and by a bone cell line, UMR (Canalis et a l, 1988c; Gray et 
a l ,  1989). IGF II is also found in the bone matrix but it is not known whether it is 
synthesised by bone cells (Canalis et a l,  1988b). IGF I stimulates collagen and matrix 
synthesis, alkaline phosphatase activity, cell replication, and provides a local mechanism 
for the action of growth hormone (Ernst and Froesch, 1988; Hock et a l, 1988; McCarthy 
et a l, 1989a; Schmid et a l, 1984). Synthesis of IGF I by bone cells is stimulated by PTH 
(McCarthy er a/., 1989b).
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Growth factor Mass Origin Action on osteoblasts
TGFB 25kD3 osteoblast^ ^ '^ 2osteoclast24 proliferation; 
alkaline phosphatase; 
collagen synthesis; 
cAMP resp to PTH;
increase '^^dzdecrease®’^ ’^2 1 ,2 2
increase2 2
decrease^’®’i^’2 iincrease^’^  b2 2
decrease^^decrease®’
SGF 83kDio proliferation; increase^^’^ ®
IGF I 7.5kD4 osteoblast^4 proliferation; increase^*!^ collagen synthesis; increase4 4 7 ,i9  
IGF I synthesis increased by;PTH2 0 ,l,25(OH)2D3i4,estradioP4^
growth hormone^
PDGF 27-30kD® proliferation; collagen synthesis; increase^ decrease1
BDGF HkD5 proliferation; 
collagen synthesis; 
alkaline phosphatase;
increase^increase®decrease2®
aFGF 16kD3 osteoblast^® proliferation; alkaline phosphatase;
increase ^ 2.13,23
decrease2®
bFGF 17kD3 osteoblast^® proliferation; collagen synthesis;
increase2’i2,i3
decrease2
Table 2. Summary of the characteristics of the main growth factors found within the bone matrix.
1 . Canalis, 1981
2 . Canalisera/., 1988a3. Canalis et a/., 1988b
4. Canalis et a l, 1988c
5. Canalis and Centrella, 1986
6 . Centrella er a/., 1987a7. Centrella era/., 1988
8 . Elford era/., 19879. Ernst and Froesch, 198810. Farley and Bay link, 1982
11. Gehron Robey et a l, 1987
1 2 . Globus e ta l,  1988
13. Globus era/., 198914. Gray et a l, 1989
15. Guenther er a/., 1988
16. Gutierrez er a/., 198717. Hock era/., 198818. Lau e ta l ,  1988
19. McCarthy era/., 1989a20. McCarthy et a l, 1989b21. Noda and Rodan, 198622. Noda and Rodan, 1987
23. Rodan et a l, 1987
24. Sandberg era/., 1988
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Platelet-derived growth factor (PDGF) is synthesised by bone cells and is found in 
the matrix (Canalis, 1988; Canalis et al., 1988b). PDGF has been shown to stimulate 
proliferation and protein synthesis. However, it can also stimulate resorption via a 
prostaglandin-dependent pathway. Acidic and basic fibroblast growth factors (aFGF and 
bFGF) are both synthesised by osteoblastic cells and are found in the bone matrix (Globus 
et al., 1989). They both stimulate bone cell proliferation causing a subsequent increase in 
collagen synthesis. Skeletal growth factor (SGF) is also found in bone matrix (Farley and 
Bay link, 1982). SGF has been shown to stimulate proliferation in primary cultures of 
chicken bone cells, however, no such stimulation occurs in the MC3T3-E1 cell line. 
MC3T3-E1 cells respond to SGF with an increase in collagen synthesis (Lau etal., 1988; 
Linkhart et al., 1986). The primary bone cells may represent a more immature cell type and 
SGF may, therefore, cause different effects in different osteogenic populations.
Bone morphogenetic protein (BMP) isolated from demineralised bone is capable of 
inducing osteogenic differentiation in connective tissue cells and was thought to be a 
glycoprotein (Urist et al., 1979). However, BMP has been found to be composed of the 
combined action of several factors (Wozney et al., 1988). At least three components of 
BMP are related to TGFB in sequence structure and another may act as a protease activator 
for TGFBi.
ii) The inorganic extracellular matrix
a) The mineral phase
Bone mineral consists of calcium phosphate crystals. The mineral is probably 
deposited as octa-calcium phosphate (CagH2 (P0 4 )6 ) but the mature form is hydroxyapatite 
(Caio(P0 4 )6 (OH)2 ) (Mann, 1988). The mineral may also contain some carbonate (Gehron 
Robey etal., 1988).
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b) Mineralisation mechanisms
Mineralisation is initiated by the nucleating action of collagen fibrils or matrix 
vesicles, depending on the type of bone.
Woven bone (primary or immature) is found in fetal tissues and in areas of rapid 
bone growth. It is covered by a thin layer of osteoid and the collagen fibrils are randomly 
orientated. Mineral crystals first appear in association with matrix vesicles. These are 
membrane-bound extracellular vesicles containing glycoproteins, lipids, alkaline 
phosphatase and mineral ions, particularly Ca2+ and Pi (McLean et al., 1987). The vesicles 
are probably derived by 'blebbing' from the cell membrane (Anderson, 1989).
Electron microscopy has shown that the earliest crystals form within matrix 
vesicles. As the crystals grow the vesicle is obliterated and the surrounding matrix is 
calcified (Bonucci, 1987). The role of alkaline phosphatase during crystal formation is 
unclear. Matrix vesicles do not always require alkaline phosphatase substrates to initiate 
mineralisation (Wuthier, 1986). It may be the Ca2+-binding properties of alkaline 
phosphatase that are important during mineralisation (de Bernard et al., 1986).
Lamellar bone (secondary or mature) is usually found in adult tissues. It is covered 
by a thick layer of osteoid and is characterised by the arrangement of the collagen fibrils 
into regular lamellae (Gehron Robey et a l, 1988). Very few matrix vesicles are found in 
lamellar bone and calcification is first seen in association with the collagen fibrils. As 
mineralisation progresses, the banding pattern is obliterated as the volume of crystal 
expands. The packing arrangement of collagen results in the formation of regular holes and 
grooves along the fibre (Mann, 1988). These spaces act as nucleators for the deposition of 
calcium phosphate. The hole zones may function as nucleators by providing the necessary 
environment for non-collagenous proteins to act as bridges between the collagen and 
mineral. It is possible that these molecules encourage mineral deposition by electrostatic 
accumulation of Ca2+ and phosphate ions. The local organisation of the ionic charge could 
result in the alignment of crystals parallel to the long axis of the collagen fibre.
The type of nucleating mechanism is dependent upon the behaviour of the 
osteoblastic cells associated with the bone. In woven bone, the osteoblasts produce a
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matrix of randomly orientated collagen interspersed with matrix vesicles. The matrix 
vesicles serve as the initiators of calcification and it is possible that the disorganisation of 
collagen precludes any nucleating capability. The differences between lamellar and woven 
bone may be due to either the presence of different osteogenic cells, although members of 
the same lineage, or the existence of differential behaviour of the osteogenic cells in 
response to local and/or systemic control.
C. BONE FORMATION
The formation of bone in vivo is, normally, a very controlled process both spatially 
and temporally. Osteogenesis occurs initially during skeletal development and then 
continues during growth. Osteogenesis also takes place in the adult animal as part of the 
normal remodelling process.
1. Developmental bone formation
There are two methods of developmental bone formation;
i) endochondral osteogenesis, characterised by the formation of a cartilage model and its 
subsequent replacement with bone, and
ii) intramembranous osteogenesis, characterised by the direct transition of mesenchyme to 
osteogenic cells without chondrogenic involvement.
i) Endochondral osteogenesis
Embryonic bone is formed from mesenchymal cells derived from the mesoderm. 
The initial formation of cartilage cells by the differentiation of mesenchyme is induced by 
short-range (matrix-mediated) interactions with surrounding epithelia (Hall, 1988). The 
cartilage model is then replaced by bone cells possibly derived by;
i) direct transformation of the cartilage cells,
ii) inductive action by the cartilage on the surrounding cells,
iii) blood-bome migration from elsewhere in the embryo.
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The appearance of osteoblasts precedes that of osteoclasts, possibly due to a 
chemoattractic response by osteoclast progenitor cells to osteoblastic products eg collagen 
and osteocalcin (Parry, 1985).
Mineralisation first occurs in the collar surrounding the middle of the shaft forming 
a ring of bone around a core of calcified cartilage. The shaft is then invaded by capillaries 
carrying in haemopoietic cells as well as undifferentiated mesenchymal cells from the 
perichondrium (Vaughan, 1981). The calcified cartilage core is then resorbed and replaced 
by bony trabeculae. Vascular invasion of the cartilaginous ends (epiphyses) occurs 
separately resulting in the formation of the epiphyseal growth plate, thus allowing 
longitudinal growth (Reddi, 1985).
It has also been suggested that instead of the cartilage rudiment forming a model for 
the bone, it may provide a model for the marrow cavity (Caplan, 1987; Caplan and Pechak,
1987). All bone formation occurs outside the first ring of diaphyseal bone while the 
cartilage model is replaced by marrow and vasculature.
Endochondral osteogenesis occurs during the development of the long bones, 
backbone, ribs and parts of the facial skeleton. Bone formed in this manner mineralises 
more rapidly than that formed by intramembranous osteogenesis (Dziedzic-Goclawska et 
al., 1988). This may reflect the functional differences between weight bearing and non­
weight bearing bones.
ii) Intramembranous osteogenesis
Osteogenesis is initiated by the differentiation of mesenchymal cells into osteoblasts 
(Marvaso and Bernard, 1977). These cells then synthesise a calcifiable extracellular matrix 
possibly containing matrix vesicles. Nucléation sites within the matrix are rich in sulphur- 
containing components, possibly proteoglycans (Arsenault and Ottensmeyer, 1984). The 
sulphur components are then overlaid by calcium and phosphorous and discrete nodules of 
bone form containing hydroxyapatite crystals. The nodules eventually coalesce to form 
seams of woven bone surrounded by a layer of fibroblasts. This sequence of events can
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occur in the absence of epithelial interactions, although they may be necessary at earlier 
stages.
Intramembranous osteogenesis occurs during the development of the skull, most of 
the facial skeleton and the clavicle.
2. Bone repair
Following a fracture the first response is acute inflammation bringing in phagocytic 
cells and systemic factors eg growth factors (Caplan, 1987). The fracture gap is then 
plugged by a blastema of mesenchymal cells, possibly derived from the pool of bone cells, 
or by chemoattraction from a blood-borne source, or from an inducible osteogenic reserve 
of perivascular undifferentiated connective tissue cells (Mikhailova and Pal'tsyn, 1986). 
The mesenchymal cells then differentiate into chondrocytes, possibly due to the action of a 
soluble factor present in bone. The chondrocytes hypertrophy and the cartilage mineralises 
before osteogenesis occurs, probably in a manner similar to that seen in endochondral 
osteogenesis.
3. Experimental bone formation
i) In vivo bone formation
Bone development can be induced following implantation of demineralised bone 
into extra-skeletal sites in vivo (Bemick et al., 1989; Harakas, 1984; Muthukumaran and 
Reddi, 1985; Urist, 1965). Induced osteogenesis by HCl-demineralised bone is initiated 
by the infiltration of connective tissue macrophages, lymphocytes and fibroblasts and the 
implant becomes covered in vascularised connective tissue (Bernick et al., 1989; Urist, 
1965). Vascular channels are then enlarged by the action of acid-phosphatase positive cells 
prior to bone formation. Following osteogenesis the implant can provide a suitable 
microenvironment for the establishment of a marrow organ by invading host haemopoeitic 
cells (Harakas, 1984).
Mesenchymal differentiation may be dependent upon the amount of vascularisation, 
as low oxygen tension encourages chondrogenesis and high oxygen tension encourages
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osteogenesis. Implants exhibiting chondrogenic differentiation and subsequent 
osteogenesis provide a model system for induced endochondral osteogenesis 
(Muthukumaran and Reddi, 1985).
There are two important events occurring here;
i) the initial attraction of mesenchymal cells and blood vessels,
ii) the subsequent induction of osteogenic differentiation.
The location of the implantation site affects the extent of bone formation. Bone and 
bone marrow yield the greatest amounts, followed by skeletal muscle, whereas testes, 
pancreas and ovary are inefficient osteoinductors (Harakas, 1984).
The inductive ability of demineralised bone is due to the presence of BMP (Urist et 
al., 1979). Other osteogenic factors can be isolated from demineralised bone matrix, as 
well as cartilage-inducing factor (Muthukumaran and Reddi, 1985). The action of BMP 
can be potentiated by interleukin-1 (IL-1) (Mahy and Urist, 1988). IL-1 may act as a 
mitogen for osteoprogenitors or it may modulate the response to BMP.
Bone can also form in vivo following the intra-rauscular transplantation of freshly 
isolated bone cells from fetal rat calvaria (Groot et al., 1983; Moskalewski et al., 1983). 
The cells start to synthesise collagen by day 2 or 3, forming islands of matrix surrounded 
by alkaline phosphatase positive cells. The first bone laid down is woven bone but by 1 to 
2 months lamellar bone predominates. Very few osteoclasts are observed and the lamellar 
bone consequently contains cores of woven bone and marrow cavities do not form. The 
lack of osteoclasts may be due to the absence of an appropriate chemoattractant in the 
transplant.
Bone cells from neonatal mouse calvaria implanted peritoneally in Millipore 
diffusion chambers also form bone (Simmons et al., 1982). Following 20 to 30 days in 
vivo the chambers are found to contain a mineralised bone matrix and alkaline phosphatase 
positive cells. The matrix and cellular composition and the time scale is similar to that for 
osteoblastic cells implanted intra-muscularly without diffusion chambers. In this latter
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case, it is as if the isolated osteoblastic cells are behaving as though they are within a sealed 
chamber, exhibiting no cellular interaction with the host.
There is, therefore, a very basic difference between bone formation following 
implantation of demineralised bone matrix and that following implantation of osteoblastic 
cells. Induction of bone formation involves the attraction, proliferation and differentiation 
of unspecialised mesenchymal cells to establish a bone organ from first principles. 
Implanted cells are obviously more differentiated initially and may have, in situ, passed 
through the stage capable of directly influencing mesenchymal cells.
ii) In vitro bone formation
a) Organ culture
Endo (1960) initially reported osteogenesis in vitro using organ culture. 
Embryonic chick femurs increased in length following culture in medium supplemented 
with chick embryo extract. However, abnormal calcification sequences were observed. 
Fetal rat radii and ulnae in organ culture are capable of collagen synthesis and both show 
increases in length (Raisz et al., 1976). Collagen synthesis was stimulated by phosphate 
and ascorbic acid and inhibited by PTH. However, fetal rat calvaria, in terms of amount of 
tissue present, are far more amenable to organ culture.
In this system, the amount of collagen synthesised is used as a measure to enable 
the quantification of bone formation. Using this criterion, it has been shown that PTH, 
EGF and tumour necrosis factor inhibit bone formation and insulin, insulin-like growth 
factor (somatomedin) and cortisol all stimulate bone formation (Canalis, 1987; Canalis and 
Raisz, 1979; Raisz et al., 1976).
Osteogenic cells from embryonic chick calvaria can be grown as an explant of the 
periosteum (Tenenbaum and Heersche, 1982). Folding the periosteum so the osteogenic 
side faces inwards onto itself results in osteoblastic differentiation and the formation of 
osteoid with a concomitant increase in alkaline phosphatase activity; these parameters of 
phenotypic expression are dependent upon the initial site of the periosteum in ovo, eg ecto- 
or endocranial (McCulloch et al., 1989). The osteoid will mineralise in the presence of
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organic phosphate to produce a mineralised matrix surrounded by unmineralised osteoid 
(Tenenbaum, 1981). Unfolded periostea exhibit osteoblastic differentiation only if they are 
cultured with the osteogenic surface facing the air, indicating a possible development of a 
microenvironment due to either apposition or restricted diffusion (Tenenbaum and 
Heersche, 1986).
b) Cell culture
Bone formation in cultures of isolated osteoblastic cells provides models to answer 
questions about the regulation and mechanisms of osteogenesis at the cellular level. A very 
early report of bone formation in vitro by isolated osteoblastic cells used cultures 
established by enzymatic digestion of periosteum-ffee fetal rat calvaria (Binderman et al., 
1974). The cells secreted a collagenous matrix that was progressively mineralised. 
However, the appearance of mineralisation was slow, the mineral crystals bore no spatial 
relation to the collagen fibres and the pattern of mineralisation was diffuse and presented no 
mineralisation front.
A later study used cultures established by migration of osteogenic cells away from 
bone fragments (Ecarot-Charrier et al., 1983). Following an initial period of outgrowth the 
cells were replated by scraping and thus at no point did the cells come into contact with 
exogenous digestive enzymes. The cultures secreted an extracellular collagenous matrix 
(primarily of type I collagen) which showed mineral deposits in the presence of organic 
phosphate. The calcified matrix contained embedded cells, each surrounded by a layer of 
osteoid, resembling the in vivo situation. Matrix vesicles were also seen within these 
cultures and these structures may have acted as nucleators although mineral crystals were 
also seen in association with collagen fibrils.
Bone cells can, therefore, synthesise an osteoid-like extracellular matrix that can 
support physiological mineralisation, despite the initial disappointing results of Binderman 
and colleagues (1974). Bone cell populations released by collagenase digestion of fetal calf 
calvaria can secrete and mineralise an extracellular matrix in vitro (Whitson et al., 1984). 
A later study showed that enzymatically released cells can form bone in vitro following
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addition of organic phosphate to the culture medium (Nefussi et a i, 1985). Periosteum- 
free fetal rat calvaria were digested using collagenase. The cells released were plated in 
medium supplemented with both ascorbic acid and 6 -glycerophosphate. The cultures were 
characterised by the early formation (day 4) of multilayered nodules of cells. By day 11 the 
cultures started to deposit mineral in discrete sites within the nodules. The formation of 
nodules may be an in vitro representation of the developmental appearance of bony 
nodules during intramembranous osteogenesis.
Structurally, the nodules are formed of cells and extracellular matrix and bear a 
close correlation to bone in vivo (Bhargava et al., 1988). The upper surface of the nodule 
is covered in a layer of cuboidal osteoblastic cells joined by adherens type junctions 
(desmosomal). These cells contain abundant cytoplasmic rough endoplasmic reticulum, 
Golgi complexes and mitochondria. Within the nodule there are osteocytic cells, 
completely surrounded by matrix. Gap junctions are present between the cell processes 
which extend into the matrix. The matrix collagen is highly organised and exhibits a 
closely packed orthogonal arrangement. Mineral crystals are found in association with the 
collagen fibres, although some matrix vesicles are also present. An unmineralised seam of 
osteoid lies between the embedded osteocytes and the mineralised matrix.
Thus, bone formed in cell culture exhibits regulated mineralisation associated with 
organised collagen fibrils and some matrix vesicles, as well as an intricate network of 
interconnected osteocytic cells within a mineralised matrix overlain by cuboidal osteoblasts.
The number of osteogenic nodules can be influenced by various factors. In the 
absence of ascorbic acid no nodules form, and in the absence of 6 -glycerophosphate no 
nodules are mineralised (Bellows et al., 1986). Addition of dexamethasone stimulates 
nodule formation, showing an effect of glucocorticoids upon skeletal tissue. Over long­
term culture, EGF causes a highly significant decrease in nodule formation by a 
prostaglandin-independent mechanism. However, short-term exposure to EGF caused a 
highly significant increase in nodule formation, possibly due to a mitogenic action on 
precursor cells.
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Undifferentiated chick limb mesenchymal cells can form bone, as well as other 
connective tissues, following culture in vitro (Osdoby and Caplan, 1979). The phenotypic 
expression by the mesenchymal cells is dependent upon the initial cell density at plating 
(Osdoby and Caplan, 1980). Chondrogenesis occurs in high density cultures, whereas 
osteogenesis and mineral deposition occurs at lower densities.
The clonal osteoblastic cell line, MC3T3-E1, is capable of secreting an extracellular 
matrix that can mineralise in vitro (Sudo et al., 1983). By day 18, the banding pattern of 
the extracellular collagen fibres became apparent and small nodules of osteoblastic cells 
began to develop by day 21. Matrix vesicles are found at day 24 and these provide 
nucléation sites for crystal formation. By day 30 mineral crystal starts to align along the 
collagen fibrils, and osteocytes within the nodules became enveloped in the mineralised 
matrix. X-ray emmission analysis shows the mineral to be composed of calcium and 
phosphorous. Addition of 6 -glycerophosphate causes a marked increase in the rate of 
mineral deposition (Kodama et al., 1986).
MC3T3-E1 cells can also form a mineralised tissue following growth and 
differentiation within a three-dimensional type 1 collagen gel matrix (Sudo et al., 1986). 
Crystal-containing matrix vesicles appears at day 15 with subsequent mineralisation of the 
matrix. Mineralisation is advanced by the addition of 6 -glycerophosphate.
c) Marrow culture
The osteogenic properties of marrow stromal cells and the possibility of an 
osteogenic stem cell are discussed in a recent review by Beresford (1989).
As has been seen, transplantation of marrow results in osteogenesis at the new site 
followed by invasion of host haemopoietic cells and the formation of a bone organ 
(Friedenstein, 1976). Marrow stromal cells in diffusion chambers in vivo can give rise to 
both osteoblastic and chondroblastic differentiation and the formation of mineralised bone 
tissue containing collagen and matrix vesicles (Ashton et a l, 1980). Histologically, the 
tissue resembles primary or woven bone with a disorganised orientation of the collagen. 
The pattern of formation is similar to that of endochondral osteogenesis during normal
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development (Mardon et al., 1987). Measurement of alkaline phosphatase activity and the 
content of calcium and phosphorous provides a method of quantifying osteogenesis (Bab et 
al., 1984). Inclusion of demineralised bone matrix stimulates osteogenesis either by the 
action of bone morphogenetic protein upon a possible lOPC fraction of marrow or by the 
action of other matrix components upon osteoblastic proliferation and synthetic ability 
(Green et al., 1986).
Marrow stromal cells maintain their osteogenic potential in diffusion chambers in 
vivo following a period of in vitro growth (Friedenstein et al., 1987). Fibroblast colonies 
can be established in vitro from bone marrow suspensions. Transplantation of cells from 
either one or several colonies results in the formation of bone and cartilage in diffusion 
chambers in vivo. This shows that within the original population of fibroblast colony- 
forming cells there exists an osteogenic potential indicating the presence of osteogenic stem 
cells. These stem cells are not distributed evenly throughout the marrow cavity. The 
efficiency of the marrow cells to form fibroblastic colonies in vitro increases through the 
sequence core and intermediate marrow towards the endosteal surface, where it is highest 
(Ashton et al., 1984). Correspondingly, osteogenic marrow stroma cells are more 
abundant towards the bone surface.
Organ cultures of adult marrow can form bone in vitro (Luriya et al., 1986). 
Marrow was cultured as explants on rafts of Millipore filters at the gas/liquid interface. The 
medium was supplemented with both ascorbic acid initially and with 6 -glycerophosphate at 
day 8 . Within the explant, condensations of cells formed, which developed into thin 
trabeculae covered in a palisade of osteoblasts. In the presence of organic phosphate the 
trabeculae mineralised after day 16. The final bony structure consisted of layers of cells 
surrounded by the mineralised matrix. Ultrastructurally, the matrix consisted of well- 
banded collagen arranged orthogonally amongst which were seen matrix vesicles (Luria et 
al., 1987). Bone marrow cultures as intact plugs covered by tissue culture medium in 
Petri dishes can form bone in the presence of ascorbic acid and 6 -glycerophosphate 
(Schoeters et al., 1988). Osteogenesis also occurs following culture of marrow cell
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suspensions applied to gelatin sponges, permitting a comparison between the initial number 
of marrow cells and the quantification of osteogenesis (Luria et al., 1988).
Maintenance of the spatial arrangement of marrow cells is not necessary for the 
expression of osteogenic potential. A single cell suspension produced by density gradient 
centrifugation of marrow cells can form osteogenic colonies following culture on adherent 
cells derived from marrow (Tibone and Bernard, 1982). The osteogenic structures consist 
of a mineralised matrix of collagen containing matrix vesicles, within which are embedded 
osteocytes. The number of osteogenic colonies formed bears a linear relationship to the 
number of cells plated, indicating the possible clonal origin of the structures from CFU-0 
(colony forming units - osteogenic), probably a DOPC. The term CFU-O has also been 
used to describe the cells within cultures derived from calvarial cells that are capable of 
initiating bone nodule formation (Bellows and Aubin, 1989).
In the absence of an adherent layer, marrow cells form fibroblastic colonies, a few 
of which express alkaline phosphatase activity (Owen et al., 1987). This indicates a 
heterogeneity amongst the colony forming population and also shows that the majority are 
very undifferentiated cells close to, if not members of, the stem cell compartment. In this 
system, the expression of alkaline phosphatase can be affected by exogenous factors; it is 
decreased by EGF and increased by hydrocortisone. This shows the prevention of 
differentiation by EGF and the activation or induction of osteogenic differentiation by 
hydrocortisone in otherwise undifferentiated colonies.
Subculture of fibroblastic colonies derived from marrow stroma results in the 
formation of confluent multilayers capable of supporting osteogenic differentiation and the 
formation of bony nodules (Maniatopoulos et al., 1988). The nodules show intense 
alkaline phosphatase activity and consist of a mineralised collagenous matrix containing 
osteocytes and overlain by osteoid and rows of cuboidal cells. The mineralised nodules 
form only in the presence of dexamethasone and organic phosphate. There is therefore a 
component within bone marrow stroma capable of forming bone in vitro without the 
maintenance of the cellular microenvironment.
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In summary, osteogenic cells are found throughout the marrow cavity, but with 
increasing frequence laterally, and also in association with the bone surface. There are 
many methods to study osteogenesis experimentally and these offer a basis for an 
understanding of the complex regulation of bone formation.
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A. ANIMALS
Neonatal CD-I mice of either sex, unless stated otherwise, housed under standard 
animal house conditions.
B. MATERIALS
Adenosine 3':5'-cyclic monophosphate, sodium salt (cAMP) - Sigma A-6885
Agar - Bacto-agar "Difco" certified 0140-02
Alkaline phosphatase - from bovine intestinal mucosa Sigma P-7640
Aquacide IH - flake polyethylene glycol, Calbiochem 17852
Araldite - Emscope
Ascorbic acid - Sigma A-0278
Aquamount - BDH 'Gurr' 36086
Benzyl penicillin, sodium - Glaxo
Bovine serum albumin - Sigma A-7906
Calcitonin (thyrocalcitonin from bovine thyroid glands) - Sigma T-8135 
Calcium chloride (CaCl2.2H20) - BDH 'AnalaR' 10071 
Calcium/phosphorous combined standards - Sigma 360-11 
Catalase - Sigma C-40
Charcoal 'Norit GSX' low in chlorine - BDH 33204 
Chloral hydrate - BDH 27668 
Citric acid - BDH 'AnalaR' 10081
Collagenase - Worthington's bacterial collagenase, class 11 Cooper Biomedical
Colourimetric calcium assay - Sigma 587-A
Copper sulphate (CUSO4.5H2O) - BDH 10091
Dexamethasone (9a-fluoro-16a-methylprednisone) - Sigma D-1756
Dialysis tubing - Medicell International Ltd
Diethanolamine - BDH 'AnalaR' 10393
Disodium hydrogen phosphate (Na2HP0 4 ) - BDH 'AnalaR' 10249 
Dispase - Protease, neutral grade II, Boehringer Mannheim 165 859
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Dithiothreitol - Sigma D-0632
Dulbecco's modification of Eagle's medium (Dulbecco's MEM) - Flow 
Eagle's minimum essential medium, Earle's salts (Eagle's MEM) - Flow 
Epidermal growth factor - Sigma E-4127
Ethylenediaminetetra-acetic acid, disodium salt - BDH 'AnalaR' 10093
Fast Blue RR salt - C.l. 37155
Fetal calf serum -Gibco
Folin Ciocalteu’s reagent - BDH 19058
Formaldehyde - BDH 'AnalaR' 10113
Forskolin, dissolved in ethanol - Sigma F-6886
L-Glutamine - Flow
Glutaraldehyde - 25% solution, BDH 36080 
Glycerol - Sigma G-7757 
6-Glycerophosphate - Sigma G-6251 
Glycine - BDH 'AnalaR' 10119 
Haematoxylin - C.l. 75290 
Horse serum - Flow 
Insulin - Sigma I-55CX)
3-Isobutyl-1 -methyl-xanthine - Sigma 1-5879 
Magnesium chloride (MgCl2.6H2 0 ) - BDH 'AnalaR'10149 
Multiwell plates - Linbro, 24 well plates 
a-Naphthyl-acid-phosphate, monosodium salt - Sigma N-7CXX)
Neutral red - BDH C.I. 5(X)40 
p-nitrophenyl phosphate - Sigma 104 
Osmium ampoule - Biorad (Emscope)
Parathyroid hormone - National Institute of Biological Standards and Control, reagent 
761572
Perchloric acid - BDH 'AnalaR' 10175 
Platelet derived growth factor - Sigma P-8147
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Potassium alum (A1K(S0 4 ).12H2 0 ) - BDH 27085
Potassium chloride (KCl) - BDH ’AnalaR’ 10198
Potassium dihydrogen phosphate (KH2PO4) - BDH 'AnalaR' 10203
Propylene oxide - BDH 28290
Silver nitrate (AgNOg) - Sigma S 6506
Sodium cacodylate - BDH 30118
Sodium carbonate (Na2C0 3 ) - BDH 1024
Sodium chloride (NaCl) - BDH 'AnalaR' 10241
Sodium dihydrogen phosphate (NaH2P0 4 .2H2 0 ) - BDH 'AnalaR' 120245
Sodium hydrogen carbonate (NaHCOg) - BDH 10247
Sodium hydroxide (NaOH) - BDH
Sodium iodate (NaI0 3 .H2 0 ) - BDH 'GPR' 30171
Sodium thiosulphate (Na2S203 .5H2 0 ) - BDH 30235
Streptomycin sulphate - Evans Medical Ltd
Sucrose - Fisons
Tartaric acid D (+) - BDH 10277
Theophylline (1,3-dimethylxanthine, phosphodiesterase inhibitor) - Sigma T-1633 
Tris(hydroxymethyl) methylamine - BDH 'AnalaR' 10315 
Trypan blue stain - Sigma T-9520 
Trypsin - Difco
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Q  BUFFER PREPARATION METHODS 
1. Buffered saline
i) Ca/Mg free phosphate buffered saline (CMF-PBS)
KH2PO4 0.4g/htre
Na2HP0 4  5.0g/Utre
NaCl 20.0g/litre
KCl 0.5g/Utre
Dissolved in distilled water, pH adjusted to 7.4.
ii) Phosphate buffered saline (PBS)
KH2PO4
N a 2 H P 0 4
NaCl
KCl
MgCl2.6H20
CaCl2.2H20
200mg/Iitre
1150mg/Iitre
8(XX)mg/litre
2(X)mg/litre
lOOmg/litre
132.5mg/Iitre
Dissolved in distilled water, pH adjusted to 7.4.
iii) Tyrode's solution 
KCl 
NaCl 
NaHCOs 
NaH2P04 .2H20
2(X)mg/litre
8 ,(XX)mg/litre
lOOOmg/litre
5.0mg/litre
Dissolved in distilled water, pH adjusted to 7.5.
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iv) Kreb's solution
NaCl 8 .0g/litre
KCl 0.402g/litre
CaCl 0.412g/litre
MgS04.7H20 0.296gAitre
NaH2.P04 0.047g/litre
KH2.PO4 0.041g/litre
INHCl 12mls
Glucose 2 .0g/litre
The pH was adjusted to 7.4 at 37°C using 14mM TRIS solution.
D. CELL PREPARATION
1. Method I
i) Dissecting medium
The dissecting medium was Eagle's MEM supplemented with 0.5% BSA and 
200U/ml catalase.
ii) Growth medium
The growth medium was Eagle's MEM supplemented with 10% PCS, 50IU/ml 
benzyl penicillin, 50/tg/m l streptomycin sulphate, 2mM L-glutamine, amino acids, 
vitamins, lOmM 6-glycerophosphate and 50/ig/ml ascorbic acid.
iii) Enzyme solutions
Two enzyme solutions were used. Collagenase (class II) at approximately 4(X)U/ml 
dissolved in CMF-PBS containing 4mM EDTA. Trypsin made up to 0.1% in 2mM EDTA 
dissolved in CMF-PBS.
Both enzyme solutions were sterilised by filtration through a 0.22/tm Millipore
filter.
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iv) Dissection
Ten neonatal mice were stunned by chilling in crushed ice and then killed by 
decapitation. Using flame-sterilised instruments in a laminar flow hood the scalp was 
completely removed to expose the calvaria. The bones were crudely dissected out and 
transferred to a sterile glass petri dish containing dissecting medium. The bones were then 
removed from this and transferred into sterile PBS in a petri dish under a dissecting 
microscope. All the sutures were carefully cut away and placed in 1ml of trypsin solution. 
The periosteum was then peeled off the bones and transferred to another 1ml of trypsin. 
The cleaned calvaria were then placed in a separate sterile glass petri dish containing 
dissecting medium.
v) Digestion
The sutures and periostea were incubated in a small sterile tube with continuous 
agitation for 30 minutes at 37°C at which time the supernatant was aspirated. The calvaria 
were incubated in a similar manner for four periods of 30 minutes, each in 1ml of 
collagenase. At the end o f each collagenase digestion the supernatant was aspirated and 
replaced with a similar volume of fresh enzyme solution.
2, Method II
i) Dissecting medium
The dissecting medium was a modified form of BGJ medium containing 
220mg/100mls sodium hydrogen carbonate (Reynolds, 1976). The medium contained 
50IU/ml benzyl penicillin, 50/ig/ml streptomycin sulphate and 2mM L-glutamine.
ii) Growth medium
The growth medium was Dulbecco's MEM supplemented with 10% PCS, 50IU/ml 
benzyl penicillin, 50/ig/mI streptomycin sulphate and 2mM L-glutamine.
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iii) Enzyme solutions
Three enzyme solutions were used. Collagenase at approximately 400U/ml 
dissolved in Tyrode's solution. Dispase dissolved in Tyrode's solution at 2mg/ml. 
Trypsin made up to 0.1% in Tyrode's solution,
iv) Dissection
Neonatal mice were killed by decapitation in lots of 3 to 5. The severed heads were 
then sterilised by brief immersion in 70% alcohol and the following procedures were then 
done under sterile conditions. The instruments were autoclaved before use and during use 
the sterility was maintained by dipping in 70% alcohol followed by flaming.
The scalp was peeled forwards to expose the calvarial bones. Using a pair of 
scissors the bones were crudely removed and transferred to a sterile glass petri dish 
containing dissecting medium. Under a dissecting microscope the sutures around the 
temporal and parietal bones were removed, including the lamboid suture and the 
interparietal bone, leaving the coronal and saggital sutures in place. The saggital suture 
was then removed by cutting very closely either side of it with a scalpel blade, taking care 
not to harm the periosteum. The calvarial halves were then transferred to another sterile 
glass petri dish containing dissecting medium.
v) Digestion
The bones were chopped up using a pair of scissors and transferred to a small 
sterile glass bottle containing a magnetic flea and 1 ml/10 mice o f dissecting medium. The 
magnetic stirrer was situated in a room maintained at 37°C. The following digestion 
procedure was used: ( 1) 10 minutes dissecting medium, (2 ) 10 minutes trypsin, (3) 30 
minutes dispase, (4) to (6) 3 x 30 minutes collagenase. Each time the supernatant was 
aspirated and the same volume of fresh digestion mixture was added to the calvaria. The 
first two aspirates were usually discarded. The dispase aspirate was centrifuged for 5 
minutes at 300g and the pellet resuspended in 1ml of growth medium; this cell suspension 
contained what was designated the early population of cells. The aspirates from the three
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collagenase digests were treated in similar manner except that they were pooled following 
centrifugation and resuspension in 1ml.
Calvarial bones 
10 minutes dissecting medium 37®C
Discard aspirate 
10 minutes trypsin
Discard aspirate 
30 minutes dispase
Centrifuge aspirate, resuspend 1ml early population 
30 minutes collagenase
Centrifuge aspirate, resuspend 1ml 
30 minutes collagenase
Centrifuge aspirate, resuspend 1ml 
30 minutes collagenase 
4Centrifuge aspirate, resuspend 1ml 
Pool suspensions from collagenase digests 
Late population
3. Method m
i) Dissecting medium
The dissecting medium was prepared as method IL
ii) Growth medium
The growth medium was prepared as method ü.
iii) Enzyme solutions
The enzyme solutions used were dispase and collagenase (200U/ml), prepared as 
method II.
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iv) Digestion
The calvarial halves were chopped once using a scalpel under the dissecting 
microscope along a line just caudal to the coronal suture. The fragments were then 
transferred to a small sterile plastic vial containing a magnetic flea and 1 ml/10  mice of 
dissecting medium. The bones were then incubated at 37°C for 10 minutes. The magnetic 
sthrer used was capable of maintaining a much slower rate of revolution of the magnetic 
flea than that used in method II. The dissecting medium was discarded and replaced with 
an equivalent volume of dispase for 30 minutes. Following this there were three 30 minute 
digestions using collagenase. The aspirates from these digests were pooled to give one 
population of bone cells.
Calvarial bones 4
10 minutes dissection medium, 37°C 
4
Discard aspirate, 30 minutes dispase
Discard aspirate, 30 minutes collagenase
Centrifuge aspirate, resuspend in 4mls growth medium 
30 minutes collagenase
Centrifuge aspirate, resuspend in 1ml 
30 minutes collagenase
Centrifuge aspirate, resuspend with 
pooled suspensions (total 5mls)
Single bone cell suspension
4. Balb/c3T3 Cell Line
i) Derivation
The cell line, 3T3 clone A31, was derived from Balb/c mouse embryos and was 
purchased from Flow.
ii) Growth medium
The growth medium was prepared as method n.
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iii) Handling
The cultures were initially passaged at day 3 following seeding at 2.0 x 10^  per 9cm 
Nunclon petri dish. The medium was aspirated and the cell layer was washed with 3.5mls 
of CMF-PBS. The plate was then incubated at 37°C with 1ml o f trypsin solution made up 
to 0.1% in CMF-PBS containing ImM EDTA. After 5 minutes 3mls of growth medium 
were added to inhibit the enzyme reaction and the resulting solution was sucked up and 
down using a sterile pipette before being transferred to a centrifuge tube. The cell 
suspension was then centrifuged for 3 minutes at 380g. The pellet was resuspended in 
growth medium and plated.
E. EXPERIMENTAL PROCEDURE
1. Viability
A viability test was performed on each separate aspirate produced using method n. 
Sterile 0.4% trypan blue stain was diluted to 0.02% with sterile PBS. This was then mixed 
1:1 with the cell suspension and incubated at room temperature. Viability was assessed by 
counting approximately 100 cells under a light microscope and determining the percentage 
that were capable of excluding the dye. Dye exclusion was assumed to correspond to 
viability.
2. Adenosine 3':5'-Cyclic Monophosphate Assay
i) Assay procedure
The assay method used was based on that published by Brown and colleagues 
(1971). A cell suspension o f bone cells was prepared using method III and was seeded 
into a multiwell plate at 2.0  x 10  ^cells/well in growth medium supplemented with 50/ig/ml 
ascorbic acid. The assay was performed at day 7 on fully confluent cultures. The media 
were aspirated and the cell layers were washed with Kreb's salt solution. The Kreb's 
solution was aspirated and 500/il of incubation medium was added to each well; (1) ImM 
IBMX dissolved in Kreb's containing 1% BSA, (2) 10/iM forskolin dissolved in Kreb’s
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containing ImM IBMX and 1% BSA, (3) ImU/ml calcitonin dissolved in Kreb's I
containing ImM IBMX and 1% BSA, and (4) lU/m l PTH dissolved in Kreb's solution |l
containing ImM IBMX and 1% BSA. The cultures were incubated at 37°C for 15 minutes. 4IThe reaction was halted by first washing the cell layers with ice-cold Kreb's and then 
incubation with 150/d of ice-cold 0.2N HCl per well for 15 minutes. The acid was then 
neutralised with 105/d of 0.5M TRIS to give a final pH of 7.5 and the supernatant and cell 
debris were transferred to small numbered tubes and then centrifuged at approximately 
940g for 15 minutes at 4°C. Aliquots (50/d) of the supernatant were incubated at 4°C for 
1.5 to 24 hours with 50/tl of tritiated cAMP (5/zCi/lOmls) and 2(X)/xl of binding protein 
solution (binding protein dissolved in 50mM TRIS solution containing 5mM MgCl2 and 
approximately 8 to lOmM theophylline and a trace of dithiothreitol). Standards containing 
known amounts o f cold cAMP (0 to 40pmoles and Immole) were also incubated and 
subsequently treated in a similar manner.
At the end of the incubation period 500/d aliquots of a suspension of 2% charcoal 
in distilled water containing 0.2% BSA were added to each assay tube and then centrifuged 
at approximately 940g for 15 minutes at 4®C. The supernatant was mixed with scintillant 
and the radioactivity was counted at 5 minutes per vial on an LKB Wallac 1214 Rackbeta 
liquid scintillation counter.
ii) Calculation of results
At ImM of cold cAMP no pH]-cAMP binds to the binding protein, this is therefore 
the blank value. At OmM of cold cAMP the maximum amount of pH]-cAMP binds; 
subtracting the blank value from this gives the maximum possible binding of radioactivity, 
termed Cq. Subtracting the blank value from the counts per minute for the standards and 
samples gives a value, C%.
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3, Histochemical Alkaline Phosphatase
i) Staining method
The slides were air dried and then fixed in acetone at 4°C for 7 minutes. Following 
fixation the slides were washed twice with tap water and then incubated for 20  minutes at 
room temperature in substrate solution: lOmg of substrate (a-naphthyl acid phosphate), 
lOmg catalyst (MgCl2.6H2 0 ) and lOmg diazotised coupler (Fast Blue RR salt) were 
dissolved in lOmls of 0.05M TRIS buffer at pH 10.0. The slides were then washed with 
tap water for 1 minute before incubation with Mayer's Haemalum for 2 minutes. The 
nuclei were then blued with tap water and the slides were mounted using Aquamount
The Mayer's Haemalum was prepared by dissolving overnight in 1 litre o f distilled 
water 50g potassium alum, Ig haematoxylin and 0.2g sodium iodate. The following day 
Ig citric acid and 50g chloral hydrate were added and the solution was boiled for 5 minutes 
in a fume cupboard. The solution was cooled and filtered before use.
ii) Primary cells
Cell suspensions were prepared following method I to produce six populations; 
sutures, periostea and four successive populations derived from collagenase digestion of 
the calvarial bones. The cell populations were further subdivided with respect to the age of 
the source animals. The neonates were used at ages 0 to 5 days. Following enzymatic 
digestion the aspirate was centrifuged at 300g for 10 minutes and the pellet resuspended in 
100/d of growth medium. A cytospin was performed on the cell suspension and the slides 
then stained for alkaline phosphatase.
iii) Cultured cells (1 to 5 days)
Cell suspensions were prepared following method II to produce two populations 
designated early and late. Cell counts were performed on both populations using a Mod- 
Fuchs Rosenthal haemocytometer and the cell concentration was adjusted to 5.0 x 10^  
cell/m l. The cell suspensions were then plated out into 30mm dishes (Sterilin) at 
1.5mls/plate. Ascorbic acid was not added to the growth medium. The cultures were
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incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 1 to 5 days. The media 
were changed every two days.
The primary cell suspension was further diluted to 2.0 x 10  ^cells/ml and cytospins 
were performed on 200/d aliquots of this suspension. These were then stained for alkaline 
phosphatase and the percentage of positive cells assessed.
After a period in culture of 1 to 5 days the medium was aspirated and the cell layer 
washed with 2mls of CMF-PBS. This was removed and replaced with 1ml of 0.1% 
trypsin in CMF-PBS containing 2mM EDTA and the plates were incubated at 37°C for 5 
minutes and checked, using a phase contrast microscope, to ensure that the cells were 
loosened from the plastic surface. Using a plugged pasteur pipette the trypsin solution was 
sucked up and washed over the surface of the plate several times. All the liquid was then 
aspirated into a centrifuge tube containing 3mls of growth medium. The cell suspension 
was centrifuged at 300g for 5 minutes and the pellet resuspended in 1ml of medium. A cell 
count was performed on part of this suspension and the concentration was adjusted to 2.0  x 
105 cells/ml. Cytospins were performed on 200/il aliquots and the slides stained for 
alkaline phosphatase and the percentage of positive cells assessed.
iv) Cultured cells (1 to 14 days)
Cell suspensions were prepared following method II to produce two populations 
designated early and late. Cell counts were performed on both populations using a Mod- 
Fuchs Rosenthal haemocytometer and the cell concentration was adjusted to 2.0 x 1Q5 
cells/ml. The cell suspension was seeded into multiwell plates at 1 ml/well. The cultures 
were incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 1 to 14 days, the 
media were changed every two days.
Cytospins were performed on 200/d aliquots of the primary cell suspension and 
these were then stained for alkaline phosphatase and the percentage of positive cells was 
assessed.
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During the incubation period the growth media were supplemented with;
a) 50)Ug/ml or 100/igAnl ascorbic add,
b) lOmM 6-glycerophosphate,
c) 50/xg/ml ascorbic acid and lOmM 6-glycerophosphate, or
d) 50/tg/m l ascorbic acid, lOmM 6-glycerophosphate and lO-'^ M 
dexamethasone.
Control cultures were unsupplemented. Other cultures were incubated for 14 days 
with various concentrations of ascorbic add (0 ,50 ,75 ,100  and 150 /tg/ml).
After a period in culture of 1, 2 ,4 , 6,1 0  or 14 days the medium was aspirated and 
the cell layers were washed with 1ml CMF-PBS. This was removed and replaced with
0.5ml of 0.1% trypsin solution in CMF-PBS containing 2mM EDTA and the plates were 
then incubated at 37°C for 5 minutes. Using a plugged pasteur pipette the trypsin solution 
was sucked up and washed over the floor of the well several times. If the culture was at 
day 10 or 14 the cultures were washed with CMF-PBS and initially incubated with 0.5ml 
collagenase (400U/ml) for 30 minutes. This was aspirated and the remaining cells 
incubated with 0 .1% trypsin.
The cells suspension was centrifuged at 300g for 5 minutes and the pellet 
resuspended. A cell count was performed and the cell concentration adjusted to 2.0 x 10^  
cells/m l. Cytospins were performed on 200/d aliquots, the slides stained for alkaline 
phosphatase, and the percentage of positive cells assessed.
4. Quantitative Alkaline Phosphatase Assay
i) Assay calibration
The assay relies upon the ability of alkaline phosphatase to hydrolyse p-nitrophenyl 
phosphate to produce p-nitrophenol and inorganic phosphate. At alkaline pH the p- 
nitrophenol is strongly absorbant at a wavelength of 410nm. The method used is based on 
that of Lowry (1955).
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The purchased alkaline phosphatase was dissolved in IM diethanolamine buffer at
O.lmg/ml and 0.2mg/ml. The phosphatase substrate p-nitrophenyl phosphate was 
dissolved in IM diethanolamine to a concentration of 15mM.
Ten assay tubes were set up containing 0 to lOO/ig of alkaline phosphatase. To 
these were added 200/d aliquots o f p-nitrophenyl phosphate. Standards o f 0 to 0.40 //mole 
p-nitrophenol were treated in a similar manner. The tubes were incubated for 30 minutes at 
37°C in a shaking water bath. The reaction was halted by addition o f 3.6mls of O.IM 
NaOH and the absorbance read at 410nm on a Philips spectrophotometer (PU 8620 
UVm S/NIR).
ii) Assay procedure
Single cell suspensions were prepared using method III and seeded into multiwell 
plates and cultured at 37°C in a humidified atmosphere of 5% CO2 in air.
Following an incubation period of up to 14 days the cultured cells were dissociated 
using enzymatic means. The media were aspirated and the cultures washed with 1ml CMF- 
PBS. The plates were then incubated for 30 minutes at 37°C with 1ml collagenase 
(200U/ml) in each well. The cell suspension was then sucked up and down using a pasteur 
pipette and transferred to a conical tube. The cell suspension was either used in this state or 
centrifuged for 5 minutes at 300g and then resuspended in 1ml of distilled water. The cell 
walls were then broken down by sonification in three bursts of ten seconds each with 
cooling in between. The sonicate was then incubated as 200 to 400//1 aliquots with 200//1 
of 15mM p-nitrophenyl phosphate in IM diethanolamine for 30 minutes in a shaking water 
bath at 37°C. Standards of 0.0 to 0.4 //m oles were treated in a similar manner. The 
reaction was halted by the addition of 3.6mls of O.IM NaOH and the absorbance read at 
410nm.
iii) Effect of ascorbic acid
Cultures were supplemented with 5 ,10 ,25 , 50,75 and 100//g/ml ascorbic acid and 
incubated for 7 days or 5, 50 and 75//g/ml for 14 days. Another set o f cultures were
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supplemented with 50//g/tnl ascorbic acid and the alkaline phosphatase content was assayed 
at day 3, 5, 7, 9, 11 and 13.
iv) Effect of organic phosphate
Cultures were supplemented with 50/tg/ml ascorbic acid and 0 ,1 , 5 and 10 mM 6- 
glycerophosphate. The alkaline phosphatase content was assayed at day 14.
v) Effect of hormones
a) Insulin
Cultures were established and supplemented with 0, 50, 500 and 5000 ng/ml 
insulin with and without 50//g/m l ascorbic acid. The alkaline phosphatase content was 
assayed at day 14.
b) Dexamethasone
Cultures were set up and supplemented with lO '^ M dexamethasone with and 
without 50/xg/ml ascorbic acid. Alkaline phosphatase content was assayed at day 14.
vi) Effect of growth factors
a) Epidermal growth factor
Cultures were set up and supplemented with 0, 5, 10 and 20 ng/ml EGF and 
50//g/ml ascorbic acid and incubated fw  7 days. Other cultures were supplemented with 0, 
1 ,5 , 10 and 20 ng/ml EGF and 50/ig/ml ascorbic acid and incubated for 14 days. At the 
end of the incubation period the cultures were assayed for alkaline phosphatase.
b) Platelet derived growth factor
Cultures were set up and supplemented with 2ng/ml PDGF with and without 
50/ig/ml ascorbic acid. The alkaline phosphatase content was assayed at day 14.
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5. Microscopy
i) Scanning EM
A cell suspension prepared following method HI was seeded into multiwell plates at 
2.0 X 105 cells/well in medium supplemented with 50/ig/ml ascorbic acid. The cultures â
were further supplemented with lOmM 6 -glycerophosphate at day 9.
At day 14 the media were aspirated and the cultures washed with a phosphate and |
calcium free buffer (TRIS 2.42g and 29.24g NaCl in lOOOmls distilled water at pH 7.5).
This was replaced with an aldehyde fix solution for 30 minutes at 4°C (sucrose 0.6g and 
lOmls 25% glutaraldehyde solution plus lOOmls buffer). The plates were then dehydrated 
with alcohol (50%, 70%, 80% and 90%, ten minutes each) and then taken through three 
changes of twenty minutes each of absolute alcohol.
The samples were then critical point dried using a Samdri 780 (Emscope). Critical 4
point drying first replaces the absolute alcohol in the sample with liquid carbon dioxide.
This is then taken to the critical point of carbon dioxide, consequently causing the 
conversion from liquid to gas. Evaporation o f liquid carbon dioxide is an exothermic 
process and would therefore cause heat damage in the sample.
Two different types o f coating were used; i) gold, and ii) carbon. Using an SC 500 
(Emscope) samples were coated with gold to a depth of lOnm and then subjected to a 
voltage o f 15kV in a JEOL JSM-35CF scanning electron microscope. Images produced 
using X-ray emission of the Ka o f calcium were overlaid onto photographs of the same 
area to produce speckle pictures representing the calcium distribution. It was not possible 
to produce a plot of the elemental distribution using this method as the phosphorous peak 
was too close to that produced by the gold coating. Further samples were therefore coated 
in carbon to a depth of 10 to 15nm using a 'Speedivac' coating unit 12E6/1688 (Edwards 
High Vacuum Ltd). These samples were exposed for 130 seconds to a voltage of 15kV 
and a plot was produced on a Link System XY recorder 26000 A4 via a Link System 
model 290 with a Kevex series #3000 cryogenic subsystem.
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ii) Transmission EM
A cell suspension prepared following method IE was seeded at 2.0 x 10^  cells/well 
into multiwell plates. The media were supplemented with 50/ig/ml ascorbic acid at seeding 
and with lOmM 6-glycerophosphate at day 9.
At days 7 ,1 0  and 14 the cultures were washed once with cacodylate buffer (0.2M  
sodium cacodylate, pH 7.3) and fixed for 30 minutes with 2.5% glutaraldehyde solution in 
cacodylate buffer. The samples were then rinsed twice with buffer and post-fixed for 30 
minutes with 1% osmium solution (5mls cacodylate buffer plus the content of an osmium 
ampoule dissolved in 5mls o f distilled water). The samples were again rinsed twice with 
cacodylate buffer and then dehydrated with alcohol (50%, 70%, 80% and 90%, ten 
minutes each) and finally taken through three changes of twenty minutes each of absolute 
alcohol. In preparation for the resin stage,#the samples had three changes of twenty 
minutes each of propylene oxide. This was followed by one hour o f two parts propylene 
oxide/one part resin (27 parts Araldite, 23 parts hardener, 1 part accelerator) and then one 
hour 2 parts resin/1 part propylene oxide. The samples were then placed in pure resin in 
foil-coated dishes and hardened at 60°C for 48 hours.
2.5% glutaraldehyde fixation
1% osmium post-fixation
Alcohol dehydration
Propylene oxide 
4Propylene oxide/resin (2:1) 
4
Propylene oxide^sin (1:2) 
Embedded in pure resin
Using a Reichart microtome and a fine glass knife sections 50 to 60nm thick were 
cut from the samples. These were mounted onto copper grids and stained with Reynold's 
lead citrate and saturated uranyl acetate in 50% alcohol. The sections were stained first
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with lead citrate for 3 minutes, washed with distilled water and then stained with the uranyl 
acetate for 3 minutes. The grids were again washed with distilled water and then dried with 
filter paper.
The sections were then visualised using a Philips 301 transmission electron 
microscope.
iii) Histology
The localisation o f insoluble calcium within osteogenic cultures was demonstrated 
using the von Kossa method. The media were aspirated, the plates rinsed with PBS and 
the cultures then fixed with 10%'formaldehyde in absolute alcohol at 4°C for 30 minutes. 
The plates were then stained for calcium using 1% aqueous silver nitrate for 15 minutes 
while exposed to a bright light Unreduced ionised silver was removed using 5% aqueous 
sodium thiosulphate for 2 minutes. Counter-staining was with 0.5% aqueous neutral red 
for 1 minute. The samples were mounted using Aquamount mountant.
Early population cells (prepared following method II) were seeded into 30mm 
tissue culture dishes (Sterilin). At day 4 the cultures were supplemented with 50;xg/ml 
ascorbic acid and lOmM 6-glycerophosphate. At day 28 the cultures were further 
supplemented with Iff^M dexamethasone and were fixed at day 42.
6 . Mineralisation in vitro
i) Experimental procedure
Single cell suspensions were prepared using method lH and seeded into multiwell 
plates and cultured at 37°C in a humidified atmosphere o f 5% CO2 in air. 6 - 
glycerophosphate (lOmM) was added to the medium at day 9. After a total period in 
culture of 14 days, the samples were fixed and stained for insoluble calcium using the von 
Kossa method.
The extent of mineralisation was semi-quantified using a Chalkley grid graticule 
inserted into a x8 eye-piece of an Olympus inverted microscope. Using a xlO objective, 
the extent of mineralisation was determined by counting the number of points on the grid
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overlying calcified areas in a total of 20 fields per sample. Mineralisation is therefore 
expressed as a percentage of the total area.
ii) Effect of hormones
a) Insulin
Cultures were established and supplemented with 0, 50, 500 and 5000ng/ml 
insulin, with and without 50/zg/ml ascorbic acid.
b) Dexamethasone
Cultures were set up and supplemented with lO-^M dexamethasone, with 50^g/ml 
ascorbic acid.
iii) Effect of growth factors
a) Epidermal growth factor
Cultures were set up and supplemented with 0, 1, 5, 10 and 20ng/ml EOF and 
50/xg/ml ascorbic acid.
b) Platelet-derived growth factor
Cultures were set up and supplemented with 0 and 2ng/ml PDGF with 50/xg/ml 
ascorbic acid.
7. Quantitative calcium assay
i) Assay calibration
The assay is based on the ability o f calcium to react with o-cresolphthalein 
complexone resulting in a purple reaction product at alkaline pH. The absorbance is read 
at 575nm and the colour intensity is proportional to the calcium concentration.
Using purchased calcium/phosphorous combined standards solutions of calcium 
from 0 to 150/xg/ml were made up. Aliquots of these standards were added to 2.5mls of
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calcium assay solution in a cuvette. The absorbance o f the assay solution at 575nm was 
read before and after addition of the standard, using distilled water as the blank.
ii) Assay procedure
Single cell suspensions were prepared using method in and seeded into multiwell 
plates at 2 X lO^/well and cultured at 37°C in a humidified atmosphere of 5% CO2 in air.
Following the incubation period of 14 days the cultured cells were dissociated using 
1 ml/well of collagenase (200U/ml) for 30 minutes at 37°C. The suspension was then 
transferred to a weighed 10ml centrifuge tube and sonicated in three 10 second bursts. The 
tubes were then transferred to an LSL Secfroid to freeze dry over night
The tubes were then reweighed and the sample resuspended in 500/xl o f 0.4M  
perchloric acid, vortex mixed, and incubated at 4°C for 2 hours. The samples were then 
centrifuged at 1800g for 15 minutes and 400/d of the supernatant used for the assay.
Aliquots of 25/xl of the sample and lOmg/dL calcium standard were added to 
2.5mls of calcium assay solution. The absorbance at 575nm was read before and after 
addition using distilled water as the blank.
iii) Effect of organic phosphate
Cultures were supplemented with 50/xg/ml ascorbic acid and 0 ,1 ,5  and lOmM 6- 
glycerophosphate.
iv) Effect of seeding density
Single cell suspensions prepared using method HI were seeded into multiwell plates 
at 1 ml/well at cell concentrations o f 0.1, 0 .5 ,1 .0 ,2 .0  and 4.0 x lO^/ml. The cultures were 
supplemented with 50/xg/ml ascorbic acid at seeding and 10m 6-glycerophosphate at day 
8 .
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8. Granulocyte/macrophage colony forming cell assay
The media consisted of Dulbecco's MEM supplemented with 50IU/ml benzyl 
penicillin, 50/xg/ml streptomycin sulphate, 2mM L-glutamine and 20% horse serum. To 
prepare a single cell suspension of bone marrow cells, the femur of a six week old male 
CD-I mouse was flushed through with medium. The suspension was centrifuged at 300g 
for 5 minutes and the pellet resuspended in medium and the cell concentration adjusted to 5 
X 10  ^to 2 X lOVml. This was then diluted xlO with medium containing 0.3% agar and 
1ml aliquot were plated out into 30mm non-tissue culture petri dishes. The cultures were 
incubated for 7 days at 37°C in a fully humidified atmosphere of 5% CO2  in air.
Experimental plates were established using conditioned media in place of 
Dulbecco's MEM. The conditioned media were collected from cultures of osteoblast-like 
cells prepared using method HI seeded at a density of 2.0 x 10  ^ cells/ml into multiwell 
plates in media supplemented with 50/xg/ml ascorbic acid. The media were changed every 
other day, centrifuged to remove most loose cells and were then put to the GM-CFC assay. 
Before use the conditioned media were supplemented with 20% horse serum. Plates for 
standardisation were set up with 100/xl of WEHI-3 conditioned medium per plate. The 
WEHI-3 conditioned medium was acquired by taking the supernatant from a mouse 
myelomonocytic cell line (WEHI-3) grown in liquid culture.
At the end of the incubation period the number and type of colonies was assessed 
using a low power microscope. The colony morphology corresponded to the cellular 
composition; macrophages formed loose colonies, granulocytes formed tight colonies and 
mixed colonies consisted of both cell types (Metcalf et al., 1966).
9. Balb/c3T3 cell line
i) Culture method
The cells were plated at a cell concentration of 2.0 x 1 CP/ml into multiwell plates at 
1 ml/well. The medium was supplemented with 50/xg/ml ascorbic acid. Two days 
following seeding the cultures were further supplemented with conditioned medium at 
concentrations of 0,10,25, 50,100 and 500/xg total protein/ml. The media were replaced
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every other day with fresh media containing both ascorbic acid and conditioned medium. 
At day 8 onwards the cultures were further supplemented with lOmM 6-glycerophosphate.
The 3T3 cells were cultured for 15 days. The media were aspirated, the cultures 
washed with CMF-PBS and then incubated for 150 minutes with 1 ml/well collagenase 
(200U/ml). The collagenase was then replaced with trypsin for 5 minutes. The total 
number o f cells dissociated from each well was counted using a Mod-Fuchs Rosenthal 
haemocytometer. The cell suspensions were sonicated in three 10 second bursts and then 
split for quantitative analysis o f calcium and protein content and of alkaline phosphatase 
activity.
ii) Preparation of conditioned medium
Conditioned media were collected from osteogenic cultures of cells prepared 
following method HI. The media were pooled and concentrated by dialysis against 
Aquacide m  at 4°C. The dialysis tubing contained pores with an average diameter of 24 Â. 
The tonicity of the medium was then restored by dialysis against PBS at 4°C.
The total protein content o f the concentrated conditioned medium was determined 
by using a method adapted from Lowry and colleagues (1951). Three solutions were made 
up: Solution A, 2mls of ION NaOH and lOmls o f 2M NaaCOa were made up to lOOmls 
with distilled water, Solution B, lOmls 1% CUSO4.5H2O and lOmls 1.3% tartaric acid 
were made up to lOOmIs with distilled water, Solution C, 1:4 dilution of Folin Ciocalteu's 
reagent with distilled water. In a spectrophotometer cuvette, 1ml solution A and 250/d 
solution B were mixed. The sample was then added as a 500/d aliquot following a xlO 
dilution with PBS. Solution C, 250/d, was added last and the cuvettes were then incubated 
at room temperature for 30 minutes in the dark. Standards of bovine serum albumin 
(0.2mg/ml to 2.0mg/ml in PBS) were treated in a similar manner. Following the 
incubation period the absorption was read at 660nm, using a cuvette with no added protein 
as a blank.
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iii) Alkaline phosphatase assay
Up to 350/xl of the sonicated sample were assayed for alkaline phosphatase activity.
iv) Total protein determination
The total protein content was assayed on 50/d aliquots of the sonicated sample.
v) Quantitative calcium assay
The sonicate was added to weighed 10ml centrifuge tubes as 1ml aliquots, frozen, 
and then freeze dried over night. The tubes plus the contents were then reweighed and the 
samples resuspended in perchloric acid, as before. The calcium content was then 
determined.
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RESULTS
1. Viability
Cell preparation following method II produced six populations, each corresponding 
to subsequent steps during the digestion procedure. The percentage viability from the first 
two populations was very low. In following preparations using this method the first two 
populations were always discarded. Populations 3 to 6  had percentage viability of >95% 
(Table 3),
Population Cell Viability Cell Number
1. Dissecting 
Medium (10 mins) 8 % 0.7
2. Trypsin 
( 1 0  mins)
1 2 % 1 . 0
3. Dispase (30 mins) 95% 2 0 . 0
4. Collagenase (30 mins) 97% 31.0
5. Collagenase (30 mins)
98% 13.0
6 . Collagenase (30 mins)
96% 1 . 2
Table 3. Viability and number of cells produced during method II for cell preparation.
Cell numbers shown as number x 10' .^
2. Adenosine 3’:5'-cyclic monophosphate assay
The concentration of cAMP within the samples can be determined from the 
regression equation of Co/C* against cAMP concentration for the standards. On the basis
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Hormone [cAMP]
CT 3.1+1.2
PTH 140.5±33.2
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1
Jthat Cq/Cx = 1 when [cAMP] is zero, a regression equation was obtained from the data 4
(coefficient of determination = 96.0%);
pmoles = 4.18(Co/Cx) - 4.18 
The cAMP concentration of the samples was calculated using this regression equation. 4
Samples incubated solely with IBMX produced too little cAMP to give an accurate J
value within the limitations of the assay. ForskoHn stimulated cAMP production to such an ÿ
extent that it was too high for the assay; this did, however, indicate the ability of bone cells i
to produce cAMP in response to appropriate stimulation. Hormonal stimulation with CT |Iand PTH caused negligible and extensive stimulation respectively (Table 4)
Table 4. Stimulation of cAMP production in bone cells by calcitonin and 
parathyroid hormone.
[cAMP] is expressed as pmoles/10*^ cells. Mean ± standard error of the mean, n = 4.
3. Histochemical Alkaline Phosphatase
i) Primary cells
The expression of alkaline phosphatase by cells associated with bone is 
characteristic of the osteoblastic phenotype (Martin et aL, 1988; Peck and Woods, 1988;
Rodan and Rodan, 1984; Sodek and Berkman, 1987). This specificity of enzyme 1 
expression allows the use of alkaline phosphatase as an osteoblastic marker.
To assess the proportion of osteoblastic cells, differential counts were performed on 
the slides of cytospins of cells extracted using method I to give the percentage of the total of 
cells positive for alkaline phosphatase. No overall difference in alkaline phosphatase
....
content was observed with respect to the age of the neonatal mice, and the data were 
therefore pooled (Table 5).
Tissue Alkaline phosphatase n
Periosteum 15.3±2.4 17
Sutures 8.3±0.7** 18
Pop^ I 17.7±2.7 18
Pop^ II 34.3±3.8** 16
Pop"in 4.7±2.3** 17
Pop"IV 33.7±3.0** 18
Table 5. Percentage primary cells positive for alkaline phosphatase extracted from neonatal mice following method I.
Alkaline phosphatase content shown as the final relative percentage. Mean ± standard error of the mean, ** p < 0 .0 1 .
The results showed the osteoblast to be more abundant in digests from the calvarial 
bones than from those of the periostea or the sutures. This indicated the need to dissect 
away, as carefully as possible, the sutures from the calvaria before the bones were 
subjected to enzymatic digestion. Due to the close contact between the periostea and the 
calvarial surfaces, removal of these membranes could easily cause damage to the bone 
surfaces. Mechanical periosteal removal was therefore not attempted.
ii) Cultured cells (1 to 5 days)
The percentage of alkaline phosphatase positive cells was assessed before seeding 
of the culture and at the end of the culture period following trypsinisation. Before plating 
59.9% ± 1 .5  (mean ± standard error of the mean, n = 25) of the early population and 
54.0% ±2.1 (n = 21) of the late population expressed alkaline phosphatase. A Student's t
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test to compare these two sets of data showed the populations to be significantly different 
(p < 0.05).
As the original alkaline phosphatase content exhibited a variation, even though small, the 
final alkaline phosphatase content was expressed as a relative value (final/original) rather 
than an absolute value.
The cell number of each culture at trypsinisation was also assessed. This gave an 
indication of the ability of each cell population to adapt to culture conditions.
No overall difference was observed either in alkaline phosphatase content or in cell 
number recovered with respect to the age of the neonatal mice, and the data were therefore 
pooled (Tables 6 a and 6 b).
Days in 
culture
Alkaline phosphatase Cell numbers
1 82.8+3.1 2.53±0,18
2 65.2±4.6** 4.08+0.44**
3 31.8+3.0** 8.90+0.92**
4 25.9+2.5** 8.19+0.65**
5 31.5±3.9** 12.73+1.10**
Table 6 a. Table showing the alkaline phosphatase content and cell numbers, after a period in culture of cells of the early population prepared 
following method n.
Alkaline phosphatase content shown as the final relative percentage. Cell numbers shown as final number x 10'^. Mean ± standard error of the 
mean, n =15, * p < 0.05, ** p < 0.01.
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Days in culture Alkaline phosphatase Cell numbers
1 56.916.1 2.3010.28
2 46.311.5 3.0510.41
3 34.913.0** 6.2410.90**
4 37.114.7* 6.8810.95**
5 46.916.5 8.1311.10**
Table 6 b. Table showing the alkaline phosphatase content and cell numbers, after a period in culture of cells of the late population prepared following method II.
Alkaline phosphatase content shown as the final relative percentage. Cell numbers shown as final number x 10'^. Mean ± standard error of the mean, n =15, * p < 0.05, ** p < 0.01.
On the basis of these data, subsequent cell preparations used neonatal mice less than 
5 days old, as judged by their lack of hair eruption. The data also showed the ability of the 
bone cell preparations to proliferate under culture conditions while maintaining reasonable 
levels of alkaline phosphatase.
iii) Cultured cells (1 to 14 days)
Before plating, 65.9% ± 2.4 (mean ± standard error of the mean, n = 12) of the 
early population and 65.5% ± 2.2 (n = 14) of the late population expressed alkaline 
phosphatase. A Student's t test to compare these two sets of data showed there was no 
statistically significant difference between them.
Statistical tests using two way analysis of variance showed that overall, following 
culture, there was no significant difference between the two populations and the data were 
therefore pooled.
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Experimental control a
6 -GP with ascorbic acid and dexamethasone < 0 . 0 1
Ascorbic acid (50/xg/ml) v.s
6 -GP with ascorbic acid <0.05
6 -GP with ascorbic acid (50/xg/ml) vf
6 -GP with ascorbic acid and dexamethasone <0.05
Table 7. Comparison using two way analysis of data of supplemented 
cultures, in terms of alkaline phosphatase.
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Unsupplemented cultures showed a steady and gradual decline in alkaline ?j
phosphatase content over the 14 day culture period. Two way analysis of variance of ♦r
experimental against control data showed a highly significant (a  < 0 .0 1 ) increase in 0
alkaline phosphatase content caused by ascorbic acid (Figure 4). Addition of 6 - H
glycerophosphate also significantly stimulated alkaline phosphatase content, but the effect %
was dissipated with time in culture (Figure 5). However, in the presence of ascorbic acid, |
6 -glycerophosphate caused a significant decrease (a  < 0.05) in alkaline phosphatase levels f
(Table 7). Addition of dexamethasone to cultures containing ascorbic acid and 6 - 
glycerophosphate caused a significant increase (a  < 0.05) in alkaline phosphatase.
Figure 4. Graph showing the effect of ascorbic acid upon alkaline
phosphatase content.
Alkaline phosphatase content is shown as the final relative percentage. Time is in days. Mean ± standard error of the mean, n = 8 . Two way analysis of variance of experimental (ascorbic acid) against control data shows a highly significant (a  < 0 .0 1 ) increase in alkaline phosphatase due to the action of ascorbic acid.
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Figure 5. Graph showing the effect of 6— glycerophosphate upon alkaline
phosphatase content.
Alkaline phosphatase content is shown as the final relative percentage. Time is in days. Mean ± standard error of the mean, n = 8 . Two way analysis of variance of experimental (G-glycerophosphate) against control data shows a highly significant (a  < 0 .0 1 ) increase in alkaline phosphatase 
due to the action of 6 -glycerophosphate.
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The addition of 50/ig/ml ascorbic acid caused a significant increase (a  < 0.05) in 
cell numbers; however, lOO^g/ml ascorbic acid and 6 -glycerophosphate had no effect 
(Table 8 ). Dexamethasone added to cultures containing ascorbic acid and 6 - 
glycerophosphate had no effect on cell number.
Experimental vs control a
Ascorbic acid (50jug/ml) <0.05
Ascorbic acid (l(X)jUg/ml) -
6 -glycerophosphate (6 -GP) -
6 -GP with ascorbic acid (50/tg/ml) vs
6 -GP with ascorbic acid and dexamethasone -
Table 8 . Comparison using two way analysis of variance of supplemented cultures, in terms of final cell number.
After 14 days in culture all concentrations of ascorbic acid produced a highly 
significant (p < 0.01) increase in alkaline phosphatase. At no concentration was there any 
effect upon cell numbers (Table 9).
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Ascorbic acid 
(Mg/nil)
Alkaline
Phosphatase
CeU Number
0 12.4+0.8 7.32+1.14
50 67.0±4.7 9.04+0.87
75 73.4±4.9 6.87+1.62
1 0 0 71.0±2.9 6.09+1.11
150 63.9±5.9 6.7310.74
Table 9. Alkaline phosphatase content and cell number following 14 days 
in culture with various concentrations of ascorbic acid.
Alkaline phosphatase content shown as the final relative percentage. Cell numbers are shown as the final number x 10'^ - Mean ± standard error of the mean, n = 8 .
4. Quantitative alkaline phosphatase assay
i) Assay calibration
The correlation of micromoles p-nitrophenol released per 30 minutes with 
micrograms alkaline phosphatase was linear up to a concentration of 25/ig alkaline 
phosphatase per sample (Figure 6 ). More concentrated samples were therefore diluted 
before being assayed.
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Figure 6 . Graph showing the relationship between p—nitrophenol release and quantity alkaline phosphatase.
The release of p —nitrophenol is shown as micromoles/30 minutes. Alkaline phosphatase is plotted in micrograms.
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ii) Effect of ascorbic acid
Analysis using a Student's t test showed that at no concentration of ascorbic acid 
was there a statistically significant effect upon the total cell number (Tables 10a and 10b). -j
Ascorbic acid did however cause significant increases (p < 0.05) in alkaline phosphatase
A time course study showed a gradual increase in alkaline phosphatase activity up 
to day 11 followed by a decline (Figure 7).
Ascorbic acid 
(Mg/ml)
Cell number Alkaline
Phosphatase
0 3.50±0.31 3.0210.48
5 4.27+0.21 4.2510.40
1 0 4.4510.11 4.1710.55
25 4.9210.09 3.3110.15
50 4.4110.27 4.8110.35*
75 3.6310.13 5.7210.18*
1 0 0 2.8610.28 5.7710.75*
Table 10a. Effect of varying concentrations of ascorbic acid upon cell numbers and alkaline phosphatase activity following 7 days in culture.
Alkaline phosphatase activity expressed as /imoles p-nitrophenol released per 30 minutes per 10  ^cells. Cell number shown as final number x 10- .^ Mean ± standard error of the mean, * p < 0.05, n = 4.
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activity at 50,75 and lOO^g/ml following 7 days in culture (Tables 10a and 10b). |
Ascorbic acid 
(/ig/ml)
Cell number AlkalinePhosphatase
0 7.83+0.57 1.57+0.08
5 8.62±1.10 1.47+0.22
50 8.90+1.00 7.26+1.82
75 8.05+0.83 4.35+1.12
Table 10b. Effect of varying concentrations of ascorbic acid upon cell 
numbers and alkaline phosphatase activity following 14 days in culture.
Alkaline phosphatase expressed as /imoles p-nitrophenol released per 30 minutes per 10  ^cells. Cell numbers shown as final number x 10'^. Mean ± standard error of the mean, * p < 0.05, n = 4,
üi) Effect of organic phosphate
At no concentration of 6 -glycerophosphate was there a significant effect upon either 
cell number or alkaline phosphatase activity (Table 11).
6 -glycerophosphate(mM) Cellnumbers
AlkalinePhosphatase
0 7.25+0.65 8.65+1.09
1 8.43+0.35 11.69+1.49
5 7.03+1.06 9.47+1.72
1 0 5.98+0.66 7.93+1.05
Table 11. Effect of organic phosphate upon cell numbers and alkaline 
phosphatase activity.
Alkaline phosphatase activity expressed as /imoles p-nitrophenol released per 30 minutes per 10  ^cells. Cell numbers shown as final cell number x 
10'^. Mean ± standard error of the mean, n = 4.
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Figure 7. Graph showing the change in alkaline phosphatase activity with time in culture.
Alkaline phosphatase activity expressed as //moles p-nitrophenol released per 30 minutes per 10  ^cells. Time is shown as days in culture.
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iv) Effect of hormones
a) Insulin (with and without ascorbic acid)
At all concentrations of insulin tested, ascorbic acid (50//g/ml) had a highly 
significant effect (p < 0 .0 1 ) upon both the cell numbers and the activity of alkaline 
phosphatase. Cultures supplemented with ascorbic acid were completely unresponsive to 
the addition of insulin. In the absence of ascorbic acid, however, insulin significantly 
decreased the cell number and increased the alkaline phosphatase activity (Table 12). 
Stimulation of alkaline phosphatase activity was, however, well below that due to ascorbic 
acid.
Insulin With ascorbic acid(ng/ml) Cell number ALP Without ascorbic acid Cell Number ALP
0 13.35+0.51 12.5912.01 7.7510.36 0.0910.01
50 14.27+1.24 15.7012.39 6.0310.41* 0.1910.07
500 13.0510.56 16.0811.33 5.0810.12** 0.1910.01**
5000 13.6011.31 16.6811.38 5.3810.33** 0 .2 2 1 0 .0 1 **
Table 12. Effect of insulin upon cell numbers and alkaline phosphatase 
activity.
Alkaline phosphatase activity expressed as //moles p-nitrophenol released per 30 minutes per 10  ^cells. Cell numbers shown as final number x IQ-^ . 
Mean ± standard error of the mean, n= 4, * p < 0.5, ** p < 0.01.
b) Dexamethasone
Dexamethasone significantly decreased the cell numbers (p < 0.01) and also caused 
a significant increase in alkaline phosphatase activity (p < 0.5). In cultures supplemented 
with ascorbic acid (50//g/ml) dexamethasone decreased the cell numbers (p < 0.01) but had 
no effect upon alkaline phosphatase. In cultures supplemented with dexamethasone, 
ascorbic acid caused a highly significant increase (p < 0 .0 1 ) in both the cell numbers and 
the alkaline phosphatase activity (Table 13).
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Dexamethasone With ascorbic acid Without ascorbic acid(M) Cell Number ALP Cell Number ALP
0 13.35±0.5i 12.59+2.01 7.75±0.36 0.09±0.01
10-7 7.70±0.86** 17.44+0.95 3.18+0.39** 1.3510.24*
Table 13. Effect of dexamethasone upon cell numbers and alkaline phosphatase activity.
Alkaline phosphatase activity expressed as //moles /?-nitrophenol released/30 minutes/10^ cells. Cell numbers shown as final number x 10' .^ Comparing lO'^M with OM dexamethasone; * p < 0.05, ** p < 0.01. Mean ± standard error of the mean, n = 4.
v) Effect of growth factors
a) Epidermal growth factor
At no concentration of EOF was there any affect upon the cell numbers. At day 7, 
EGF caused inhibition of alkaline phosphatase activity (Figure 8 ). However, by day 14 
this effect was no longer present (Table 14).
b) Platelet-derived growth factor
PDGF had an inhibitory effect upon the cell numbers regardless of the presence or 
absence of ascorbic acid. The effect of PDGF upon alkaline phosphatase activity was not 
straightforward. In the presence of ascorbic acid PDGF caused a highly significant 
decrease in the enzyme activity. However, in the absence of ascorbic acid PDGF caused a 
significant increase.
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EGF
(ng/ml) 7 days Cell number ALP
14 days Cell number ALP
0 11.90±0.96 0.51+0.04 7.60+2.13 6.0511.87
1 10.05±1.05 0.31+0.02* 11.93±1.02 2.42+0.28
5 12.62±1.18 0.24+0.01** 7.55+1.70 0.52+0.17
1 0 10.93+1.06 0.23+0.01** 5.35+1.43 0.7310.32
2 0 12.15±0.99 0 .2 2 ±0 .0 2 ** 2.75±0.81 2.0310.82
Table 14. Effect of EGF upon cell numbers and alkaline phosphatase activity in the presence of ascorbic acid.
Alkaline phosphatase activity expressed as ^m oles p-nitrophenol released/30 minutes/10^ cells. Cell numbers shown as final number x lO^ L Mean ± standard error of the mean, n = 4, * p < 0.05, * * p <  0.01.
PDGF With ascorbic acid Without ascorbic acid(ng/ml) Cell numbers ALP Cell numbers ALP
0 7.9210.77 7.3210.91 7.7510.36 0.0910.01
2 4.8510.73* 0.2710.02** 1.7510.31** 0.2910.05*
Table 15. Effect of PDGF upon cell numbers and alkaline phosphatase activity.
Alkaline phosphatase activity expressed as //moles p-nitrophenol released/ 
30 minutes/ 10^ cells. Cell numbers shown as final number x 10*^ . 
Comparing with PDGF to without; * p < 0.05, * p < 0.01. Mean ± standard error of the mean, n =4.
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I
Figure 8 . Graph showing the effect of EGF upon alkaline phosphatase 
activity.
Alkaline phosphatase activity is expressed as micromoles p—nitrophenol released per 30 minutes per 10  ^cells. [EGF] is shown in ng/ml. Mean ± 
standard error of the mean, n = 4.
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5. Microscopy
i) Scanning EM
The surfaces of 14 day cultures of bone cells were found to be covered in large 
flattened cells upon which were scattered small rounded cells. Large nodular structures 
were also apparent rising up above the main culture surface. Overlaying images of the X- 
ray emission of the K a of calcium onto corresponding micrographs showed distinct 
localisation of calcium within the nodules suggesting discrete patches of cell proliferation i
combined with calcium deposition, ie an osteogenic nodule (Figure 9).
A plot of the X-ray emission analysis showed major peaks for phosphorous and the j
K a of calcium, with minor peaks for sodium, sulphur and the K6  of calcium (Figure 10). ÿ
ii) Transmission EM
At 7 days the cultures had formed multilayers of cells with banded collagen fibres 
present in the extracellular spaces (Figure 11). The cytoplasm of the cells contained 
numerous mitochondria and extensive rough endoplasmic reticulum, an indication of active 
protein synthesis.
At 10 days the collagen fibres within the extracellular spaces were more abundant 
and in some areas were arranged in a very regular manner. Rough endoplasmic reticulum |
and mitochondria are still apparent within the cytoplasm of the cultured cells (Figure 12).
Matrix vesicles were also present in the cultures and were found in areas of highly 
disorganised collagen fibres (Figure 13).
At 14 days the cultures contained calcified osteogenic nodules. These consisted of 
discrete areas of mineral deposited into the extracellular space. The mineralisation front 
was formed by deposition of spicules of mineral along the collagen fibres perpendicular to 
the banding pattern (Figure 14). The collagen fibres formed the framework upon which 
mineral was deposited. The mineral extended up to an unmineralised seam surrounding the 
cells within the nodule (Figure 15). In the centre of the nodule there were cells completely 
surrounded by mineral (Figure 16). These cells resembled osteocytes very closely. Cells
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on the surface of the multilayered cultures were rounded up and the cytoplasm contained 
mitochondria but very little rough endoplasmic reticulum (Figure 17).
iii) Histology
Confluency was reached 2 to 3 days following seeding with the cells exhibiting a 
polygonal morphology (Figure 18). The cultures rapidly developed multilayers with areas 
of nodule formation. In the absence of 6 -glycerophosphate there was no calcium 
deposition whereas with 6 -glycerophosphate calcification was localised to within the 
nodules (Figures 19a and 19b).
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Figure 9. (Mag. x 4(X))
Transmission electron micrograph of the surface of a 14 day 
old primary culture of neonatal mouse calvarial osteoblasts showing 
an osteogenic nodule (N). A speckled image of the X-ray 
emmission of the K a of calcium was overlaid, showing the 
localisation of calcium to the nodule.
86

Figure 10.
A plot of the X-ray emmission analysis of a mineralised 
osteogenic nodule. There are prominent peaks for phosphorous (P) 
and calcium (Ka), with small peaks for sodium (NA), sulphur (S) 
and calcium (KB).
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Figure 11. (Mag. x 30,700)
Transmission electron micrograph ôom a 7 day old culture.
Figure 12. (Mag. x 28,170)
Transmission electron micrograph from a 10 day old culture.
The cultures have started to form multilayers of cells. The 
cytoplasmic organelles are characteristic of cells involved involved 
in active protein synthesis; mitochondria (MC) and rough 
endoplasmic reticulum (RER). The extracellular spaces contains 
collagen fibrils in transverse (TS) and longitudinal section (LS).
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Figure 13. (Mag. x 42,650)
Transmission electron micrograph from a 10 day old culture. 
The extracellular space contains abundant collagen fibrils in 
transverse (TS) and longitudinal section (LS). The collagen fibrils 
appear to be randomly arranged and are interspersed with matrix 
vesicles (MV).
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Figure 14. (Mag. x 56,350)
Transmission electron micrograph from a 14 day old culture. 
Mineral (M) has been deposited on a framework provided by the 
collagen fibrils (C). Spicules (S) of mineral are extending along the 
fibrils and lie parallel to the main axis of the fibril. Transverse 
banding (B) with a periodicity of approximately 62nm is apparent on 
the fibrils.
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Figure 15. (Mag. x 67,050)
Transmission electron micrograph from a 14 day old culture. 
The extracellular space has been filled with mineral (M). The 
osteoblasts is still capable of protein synthesis, as shown by the 
presence of mitochondria (MC) and rough endoplasmic reticulum 
(RER). Between the cell and the mass of mineral lies an 
unmineralised seam of osteoid (O).
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Figure 16. (Mag. x 10,820)
Transmission electron micrograph from a 14 day old culture. 
An osteocyte (OC) has become completely surrounded by mineral 
(M). An unmineralised seam of osteoid (O) is apparent, separating 
the cell from the mineral. The cell is extending processes (P) 
towards the mineral, one of which is lying in a canaliculum.
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Figure 17. (Mag. x 14,250)
Transmission electron micrograph from a 14 day old culture. 
A rounded cell lying on the surface of a nodule. The cytoplasm 
contains mitochondria (MC) and some rough endoplasmic reticulum 
(RER).
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Figure 18. (Mag. x 140)
Phase contrast light micrograph of a culture of 2 to 3 day old 
primary osteoblasts. The cells have formed a monolayer of 
polygonal cells.
94
%
Figure 19a. (Mag. x 160)
Light micrograph of osteoblasts cultured with ascorbic acid 
and without 6 -glycerophosphate. Osteogenic nodules have formed 
(N). However, these are unmineralised due to the lack of 
phosphate.
Figure 19b. (Mag. x 160)
Light micrograph of osteoblasts cultured with ascorbic acid 
and 6 -glycerophosphate. An osteogenic nodule (N) has formed and 
has mineralised. Insoluble calcium is shown by the presence of 
black deposits of silver.
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NI N
Dexamethasone Calcification
(M)
0 13.6+1.4
10-7 7.210.3*
Table 16. Data showing the effect of dexamethasone upon the extent of calcification.
Extent of calcification expressed as a percentage of the total area. Mean ± standard error of the mean, n = 4. *, p = 0.05.
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6 . Mineralisation in vitro
i) Effect of hormones
a) Insulin
At low concentrations of insulin, no calcified matrix formed in the absence of |
ascorbic acid. However, patches of mineral appeared in cultures supplemented with 
5000ng/ml insulin. The percentage of the area mineralised was minimal; 0.510.2 (n = 4).
In the presence of ascorbic acid, insulin caused a significant increase (p < 0.05) in 
the area of calcification at 500ng/ml, and a highly significant increase (p < 0.01) at ï
5000ng/ml (Figure 20).
b) Dexamethasone
In the presence of ascorbic acid, dexamethasone caused a marginally significant 
decrease (p = 0.05) in the area of calcification (Table 16).
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Figure 20. Graph showing the effect of insulin upon the extent of
mineralisation.
Calcification expressed as a percentage of the total area. [Insulin] shown as the log (ng/ml). Mean ± standard error of the mean, n = 4.
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b) Platelet-derived growth factor
In the presence of PDGF (2ng/ml) there was no observable calcification. The 
percentage of the total area calcified in control cultures was 3.7±0,8 (mean ± standard error 
of the mean, n = 4).
7. Quantitative calcium assay
i) Assay calibration
The correlation between the change in absorbance and the concentration of soluble 
calcium was linear within the range tested.
ii) Effect of organic phosphate
Addition of organic phosphate caused a significant increase in calcium deposited at 
5mM and a highly significant increase at lOmM. There was no effect upon cell numbers 
(Table 17).
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ii) Effect of growth factors
a) Epidermal growth factor
EGF caused a highly significant (p < 0.01) decrease in calcification at all % 
concentrations tested (Figure 21).
Figure 21. Graph showing the effect of epidermal growth factor upon the
extent of calcification.
Calcification expressed as a percentage of the total area. [EGF] shown as ng/ml. Mean ± standard error of the mean, n =4.
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6 -glycerophosphate(mM)
Cell numbers Calcium content
0 7.25±0.65 0.8+0.3
1 8.43±0.35 1 . 1 +0 . 1
5 7.03+1.10 33.2+9.3*
1 0 5.97+0.66 51.1+7.4**
Table 17. Effect of organic phosphate upon cell numbers and calcium content.
Calcium content expressed as /xg/10^ cells. Cell numbers shown as final number x 10'^. Mean ± standard error of the mean, n = 4, * p < 0.05, ** p 
< 0.01.
iii) Effect of seeding density
The cell concentration at seeding had a highly significant effect upon the cell density 
at the end of the culture period. Despite this, however, there was little significant effect 
upon the dry weight of each sample, suggesting that the measurement of the dry weight of 
the samples was not as accurate and reliable as counting the cell numbers. The amount of 
calcium deposited was significantly increased by increasing the seeding density (Table 18).
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Seeding
(xl05)
Dry
weight
(mg)
Cell
number
Calcium 
Oug/mg dry weight)
Calcium
(/ig/lO^cells)
0 . 1 7.7+0.2 3.68+0.45 0 .1 +0 . 1 2.411.5
0.5 8.8+0.4 13.50+0.39 2.010.3* 12.711.5**
1 . 0 8.5+0.1 19.55+0.87 5.810.1** 25.614.4*
2 . 0 7.9+0.6 22.08+1.60 3.811.1* 13.213.4*
4.0 8.510.2 26.05+0.77 5.211.5* 17.415.6
Table 18. Effect of seeding density upon calcium deposition.
Cell numbers shown as final cell number x 10’^ . Mean ± standard error of the mean, n = 4, * p < 0.05, ♦* p < 0.01.
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8 . Granulocyte/macrophage colony forming cell assay
Cultures plated without WEHI-3 or bone cell conditioned medium produced no 
colonies. Parallel cultures supplemented with WEHI-3 produced 38.0 ± 5.8 colonies 
(mean ± standard error of the mean, n = 4).
Addition of bone cell conditioned medium to the cultures resulted in the stimulation 
of colony formation due to the presence of a colony stimulating factor (Figure 22). CM 
from older osteogenic cultures contained more CSF, as shown by the increase in colony 
formation.
The proportion of colony types was initially no different from that found in WEHI-3 
stimulated cultures (Table 19). From day 4 to 8  the percentage of loose colonies formed 
was significantly less than that in WEHI-3 stimulated controls. The percentages of mixed 
and tight colonies were increased over controls. This indicates the transient presence of 
some factor other that GM-CSF, possibly M-CSF.
Colonytype Days2 4 6 8 1 0  1 2
Loose 17.4±10.0 6.1+34.4** 75.9+4.8* 83.6±1.8* 98.07+2.3 89.8±2.3
Mixed 31.7±8.9 11.3±9.4 23.7+4.0* 16.4+1.8* 1.710.7 9^211.3
Tight 50.9+13.0 82.6+10.0* - - -
Table 19. Table showing the percentage of colony types following stimulation with bone cell conditioned medium.
Loose - colonies of macrophages. Tight - colonies of granulocytes. Mixed - colonies of both macrophages and granulocytes. The age of the bone cell cultures at the time of con^tioned medium collection is shown in days. Mean ± standard error of the mean, n = 4. Comparing experimental cultures with cultures supplemented withWEHI-3 (GM-CSF), * p < 0.05,
* * p <  0 .0 1 .
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Figure 22. Graph showing the effect of culture age upon the ability of the conditioned medium produced to stimulate colony formation.
Colonies shown as the number of colonies formed relative to WEHI-3 stimulated controls. This is plotted against the age of the bone cell culture when the conditioned medium was harvested. Mean ± standard error of the mean, n = 4. I
a
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9. Balb/c3T3ceUline
i) Conditioned medium
Conditioned medium was collected from osteogenic cultures of neonatal mouse 
osteoblasts. Following concentration by dialysis, the total protein content of the 
concentrated conditioned medium was found to be 13.7mg/ml.
ii) Alkaline phosphatase assay
At no concentration tested did supplementation with bone cell conditioned medium 
have any effect upon the expression of alkaline phosphatase by 3T3 cells (Table 20).
iii) Protein content
There was no effect of CM upon the protein content of cultured 3T3 cells expressed 
as /tg total protein/10^ cells. At 10/tg/ml, CM caused a marginally significant decrease in 
3T3 cell numbers, rising to a highly significant increase in cell numbers at 500/ig/ml.
iv) Calcium deposition
Any calcium deposited by the 3T3 cells was in such small quantities as to be 
undetectable using the standard assay method.
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CM(/tg/ml) Cell Number AlkalinePhosphatase
0 8.70+0.38 0.0610.01
1 0 7.28+0.39* 0.0710.01
25 8.7010.21 0.0610.00
50 8.9310.12 0.0610.00
1 0 0 9.6010.39 0.0710.01
500 13.6510.46** 0.0510.00
Table 20. Effect of bone cell conditioned medium upon Balb/c 3T3 cells.
Alkaline phosphatase activity expressed as /imoles p-nitrophenol released/30 minutes/10® cells. Cell numbers shown as find cell number x 10'®. Mean ± standard error of the mean, n = 4, * p < 0.05, ** p < 0.01.
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1. Osteoblasts in vitro
i) Methods of isolation
Three different methods were used to obtain populations of osteoblasts from 
neonatal mice. Briefly, method I was used to determine the distribution of alkaline 
phosphatase positive cells within the calvarial tissues. Method II followed a more involved 
digestion procedure and was used to assess the ability of two populations, over a range of 
neonatal ages, to express alkaline phosphatase in culture. Method III used the same 
enzymatic regimen (except for the lack of trypsin) as method H. The rate of rotation of the 
magnetic flea agitating the digestion mixture was much slower and consequently the rate of 
release of cells from the calvaria was greatly delayed. The cells released were pooled to 
form one population and this provided the basis for all subsequent experimental work 
involving bone cell cultures.
The data in Table 5 show the percentages of alkaline phosphatase positive cells 
recovered from the periosteum, sutures and the calvaria. The sutures contained very few 
osteoblasts, but this is to be expected as they are fibrous connective tissue structures 
containing large numbers of fibroblasts (Yagiela and Woodbury, 1977). The sparsity of 
osteoblasts within the periosteum was surprising since this tissue has been shown to have 
a high osteogenic potential in vitro (Tenenbaum and Heersche, 1982). However, this may 
be due to;
i) the osteogenic cells within the periosteum belonging to the osteoprogenitor |
compartment, and therefore probably alkaline phosphatase negative, or |
ii) a species difference between mice (used in this study) and chicks (used by Tenenbaum 
and Heersche, 1982), or
hi) incomplete removal of the periosteum leaving a basal osteogenic layer still attached to i
the calvaria, or I3iv) damage and death of osteoblasts during periosteal removal. 1
The populations derived from the calvaria showed an increasing abundance of 
osteoblasts as the digestion procedure progressed, reaching a peak in the third population. 
This is in agreement with Wong and Cohn (1975) who found a peak of cAMP 
responsiveness to PTH in populations 4 and 5, out of 6  in total. Population I obviously 
contains a large proportion of non-osteoblastic cells and these may well be cells associated 
with the blood vessels, bone lining cells and fibroblastic remnants of the periosteum. This 
first collagenase digestion could therefore function as a 'cleaner', freeing a large number of 
non-osteoblastic cells from the calvaria. The subsequent populations (II, III and IV) 
contained significantly more osteoblasts, suggesting that these digestions are removing 
cells directly associated with the bone. The alkaline phosphatase negative cells may 
represent fibroblasts, osteoprogenitors and cells derived from the developing marrow 
(Yagiela and Woodbury, 1977).
Method n  was based on that used by Heath and colleagues (1984). The periosteum 
was left intact and the saggital suture was removed by careful dissection. Even though the 
periosteum contained few osteoblasts, it was felt that mechanically stripping away the 
membrane would damage underlying osteoblasts. The calvaria were first digested with 
trypsin for 1 0  minutes, at which time the supernatant was discarded and replaced with 
dispase. The cells released during this period were termed the early population. The 
pooled cells from the three subsequent collagenase digestions were termed the late 
population.
Both populations of bone cells grew well in culture (Tables 6 a and 6 b). However, 
the early population had a greater rate of proliferation, and this may reflect a substantial 
fibroblastic component, possibly derived from the periosteum. Also, both populations 
showed an initial drop in alkaline phosphatase followed by a rise over the time course of 
the experiment. The rise was such that by day 5 of cultures of the late population, the 
amount of alkaline phosphatase was not significantly different from that at day 1. This can 
be explained by regarding each population as being composed of two sub-populations, 
osteoblastic and non-osteoblastic, although this is probably an over simplification.
108
The non-osteoblastic cells of the early population were in the minority at seeding. 
However, they were highly prolific and quickly over-ran the slower growing osteoblasts. 
The rise in the relative proportion of osteoblasts at day 5 may represent the start of the log 
phase of growth of these cells as the non-osteoblastic cells started to plateau. The non- 
osteoblastic cells in the late population appeared to be less prolific and the proportion of 
osteoblasts started to rise at an earlier stage. This may be due to the non-osteoblastic cells 
of the late population belonging to a more differentiated compartment than those of the early 
population, and consequently possessing a reduced proliferative potential.
Interestingly, comparison between parts 2ii) and 2iii) shows an increase in the 
proportion of osteoblasts extracted, although ostensibly using the same method. All things 
being equal, this may reflect an increase in technical standard and care during handling of 
the tissue.
Method m  was basically very similar to method II. However, the initial trypsin 
digest was absent and, more importantly, the rate of agitation of the digestion mixture (by a 
magnetic flea) was much slower. This resulted in a delayed release of cells. The dispase 
digest was used to remove periosteal cells which were assumed to have a correlation with 
the highly proliferative, non-osteoblastic cells in population I (method I) and the early 
population (method H).
ii) Viability
The viability of the cells released was assessed solely for enzymatic digestion 
following method II (Table 3). Viability was determined by measuring the ability of the 
cells to exclude trypan blue, as it was assumed that only live cells were capable of 
excluding the dye. The first two populations of cells released contained very few cells, a 
large majority of which were unviable. The sparsity of cells is probably due to the 
shortness of the digestion periods. These initial populations represent a wash and short 
digest of the calvarial surfaces and would, therefore, be expected to contain blood cells, 
non-adherent dead cells and cells damaged during dissection by exposure to air and by the 
physical actions of dissection.
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The four subsequent 30 minute digestions contained large numbers of cells and had 
a percentage viability of ^95%. The high viability and cell yield suggested that these 
populations would be suitable for establishing cultures of bone cells. The third population 
(dispase) was seeded as the early population and populations 4 to 6  were seeded as the 
late population.
iii) Expression of the osteoblastic phenotype
It has been seen that the bone cells were capable of expressing alkaline phosphatase 
following a period of growth in vitro (Tables 6 a and 6 b) and that this is a characteristic of 
the osteoblastic phenotype. Bone cells in vitro can also be characterised by their ability to 
produce cAMP in response to hormonal stimulation by both PTH and CT (Rodan and 
Rodan, 1974; Wong and Cohn, 1974). It is different populations, however, acting as the 
target cell for each hormone (Wong and Cohn, 1975). Biochemical characterisation of the 
two target cell types led to the conclusion that response to PTH by cAMP production 
indicated a cell population enriched for osteoblasts. The other cell population responded to 
both PTH and CT and it was thought to consist of osteoclasts and osteocytes (Luben et al.y 
1976). The osteoblastic nature of the PTH-responsive cells is given further credence by the 
predominance of this cell type in periosteum-free calvaria (Peck et al., 1977). The 
response to PTH and CT within the assay system employed here is therefore characteristic 
of a strong osteoblastic presence in the cell population.
2. Expression of alkaline phosphatase in vitro
Although the role of alkaline phosphatase in bone is unclear, the expression of this 
enzyme is characteristic of the osteoblastic phenotype (Rodan and Rodan, 1984). It is 
reasonable, therefore, to use this as a marker of osteogenic differentiation in cultures of 
bone cells. Two methods were used to assay for alkaline phosphatase; a histochemical and 
a quantitative method. Histochemical localisation of alkaline phosphatase provided 
information concerning the proportion of enzyme-positive cells, whereas the quantitative 
method gave a measure of the enzyme activity.
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i) Effect of ascorbic acid
Bone cells cultured for up to 14 days in unsupplemented growth medium (controls) 
showed a general decline in alkaline phosphatase levels. The effect of ascorbic acid was 
very pronounced causing a highly significant increase in alkaline phosphatase expression, 
and this implied a profound role in osteogenic differentiation (Figure 4). Ascorbic acid has 
also been shown to have significant stimulatory effects upon alkaline phosphatase in short­
term cultures of an osteoblast cell line, UMR-106 (Sugimoto et a i, 1986).
Initially, ascorbic acid appeared to have no affect upon alkaline phosphatase 
expression. However, by day 4 the level of enzyme expression started to rise and then 
plateau. This was an extension of the phenomenon seen in Tables 6 a and 6 b and would 
have the same underlying cause. The prolonged time course shows that a state was reached 
in which the proportion of alkaline phosphatase positive cells was relatively steady, 
indicating that the osteoblastic and non-osteoblastic populations reached an equilibrium.
Ascorbic acid was found to have no inhibitory effect upon proliferation, indeed at 
50/xg/ml there was a significant increase over the 14 day culture period (Table 8 ). 
However, at day 14, a Student's t test showed that various concentrations of ascorbic acid 
had no effect upon cells numbers over control levels (Table 9). Ascorbic acid has been 
shown to be toxic under aerobic conditions due to the formation of hydrogen peroxide 
(Koch and Biaglow, 1978);
ascorbic acid + 0 % > H2 O2  + dehydroascorbic acid 
Under hypoxic conditions, ascorbic acid is not toxic. The lack of toxicity due to the 
action of ascorbic acid in this system was possibly due to the ability of the osteoblastic cells 
to form multi-layers very quickly following confluence. In this state, only the uppermost 
cells would experience maximally aerobic conditions and the underlying cells would be 
protected against the toxicity of ascorbic acid by the relative lack of oxygen. This is, 
however, very speculative.
Ascorbic acid caused a significant increase in alkaline phosphatase activity at day 7, 
however, this disappeared by day 14 (Table 10). As has been seen, the proportion of cells
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expressing alkaline phosphatase is increased significantly by ascorbic acid (Figure 4). 
Therefore if the percentage of alkaline phosphatase positive cells has increased while there 
is no change in the enzyme activity then the activity per alkaline phosphatase positive cell 
has decreased. This may represent a decline in activity as osteoblasts differentiate into 
osteocytes. Figure 7 shows the gradual increase and the decline in alkaline phosphatase 
with time in culture. Ascorbic acid had no effect upon cell numbers at two time points (7 
and 14 days), indicating a lack of any toxic action.
These results show a pronounced effect of ascorbic acid upon osteoblasts: the 
vitamin is required for maintenance of alkaline phosphatase levels. Ascorbic acid is also 
necessary for the production of collagen (de Clerk and Jones, 1980). In the absence of 
ascorbic acid, under-hydroxylated collagen is produced (Pinnell et al., 1987). Ascorbic 
acid has also been shown to stimulate both alkaline phosphatase expression and collagen 
synthesis in primary cultures of embryonic chick chondrocytes (Habuchi et al., 1985). An 
approximation to the full expression of the osteoblastic phenotype in vitro is therefore 
dependent upon the addition of ascorbic acid to the culture medium.
ii) Effect of organic phosphate
The decline in alkaline phosphatase levels apparent in control cultures was delayed, 
but not prevented, by the addition of organic phosphate to the culture medium (Figure 5). 
However, the delay was such that 6 -glycerophosphate caused a highly significant increase 
in alkaline phosphatase expression over control levels. In the presence of ascorbic acid, 
however, 6 -glycerophosphate caused a significant decrease in alkaline phosphatase levels 
(Table 7). Although by day 14 this was no longer significant as organic phosphate had no 
effect upon cell numbers or alkaline phosphatase activity over a range of concentrations 
(Table 11).
Other studies have shown that 6 -glycerophosphate can cause a significant decrease 
in alkaline phosphatase activity. Tenenbaum and colleagues (1986) found that lOmM 6 - 
glycerophosphate inhibited alkaline phosphatase activity by day 6  in explants of embryonic 
chick periostea in the presence of ascorbic acid. Ashton and colleagues (1986) also found
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inhibition of alkaline phosphatase activity by day 6  in passaged cells grown out from 
fragments of human bone in the presence of ascorbic acid. Therefore 6 -glycerophosphate 
stimulates alkaline phosphatase levels in the absence of ascorbic acid, and inhibits alkaline 
phosphatase in the presence of ascorbic acid. The inhibition is transient, however, as it has 
disappeared by day 14.
6 -glycerophosphate can act as a substrate for alkaline phosphatase and is 
hydrolysed to release phosphate (Stinson and Chan, 1987). However, phosphate is a 
competitive inhibitor of alkaline phosphatase, due probably to its structural resemblance to 
6 -glycerophosphate. Therefore, in the absence of ascorbic acid, alkaline phosphatase 
levels are not elevated and the ratio of 6 -glycerophosphate to alkaline phosphatase is higher 
than it is in the presence of ascorbic acid. The high comparative concentration of 6 - 
glycerophosphate will therefore overcome inhibition due to phosphate, and indeed, alkaline 
phosphatase levels are increased.
In the presence of ascorbic acid, alkaline phosphatase activity is stimulated and 
therefore the ratio of 6 -glycerophosphate to alkaline phosphatase is lowered, allowing 
inhibition by phosphate. However, in prolonged culture with ascorbic acid the level of 
alkaline phosphatase activity reaches a plateau, therefore as 6 -glycerophosphate is added to 
the culture at media changes the ratio of 6 -glycerophosphate to alkaline phosphatase will 
rise and inhibition due to phosphate will be overcome, ie inhibition is transient and 
disappears by day 14.
iii) Effect of hormones
a) Insulin
Insulin has also been shown to stimulate cell proliferation in cultures of neonatal rat 
bone cells and UMR-106 cells, a rat osteosarcoma cell line (Schmid et a l, 1984; Hickman 
and McElduff, 1989). The primary cultures of rat osteoblasts were incubated with serum- 
free medium containing insulin from day 1 to day 7. This caused an increase in the cell 
numbers and alkaline phosphatase activity. The UMR-106 cells were exposed to insulin 
for 20 hours following confluence, and this caused an increase in cell replication. By day
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14, however, there was inhibition of replication in mouse osteoblasts cultured in the 
absence of ascorbic acid (Table 12). This may be due to an initial stimulation of division 
with a subsequent depletion of the proliferative pool.
Insulin stimulates alkaline phosphatase activity in cultures of neonatal rat 
osteoblasts and organ cultures of fetal rat calvaria (Schmid et al., 1984; Canalis, 1983a). 
However, insulin has also been shown to inhibit alkaline phosphatase activity in a rat 
osteosarcoma cell line, ROS (Levy et al., 1986). In this study, neonatal mouse osteoblasts 
responded to insulin (and only in the absence of ascorbic acid) with an increase in alkaline 
phosphatase activity by day 14 in culture (Table 12). The inhibition of alkaline 
phosphatase activity in cultures of ROS cells only occurred at sub-confluence. Insulin had 
no effect upon alkaline phosphatase activity at confluence. It would seem, therefore, that in 
the absence of ascorbic acid, insulin first inhibits and then stimulates alkaline phosphatase 
activity in sub-confluent and post-confluent cultures respectively. The absence of an 
insulin-induced effect in the presence of ascorbic acid maybe due to swamping, as the 
stimulation caused by 5000ng/ml insulin is a very small fraction of that caused by 50/ig/ml 
ascorbic acid (Table 12). The effect of insulin (but only in the absence of ascorbic acid) is 
to inhibit proliferation while stimulating differentiation.
b) Dexamethasone
Over the 14 day culture period, dexamethasone (lO-^M) had a significant 
stimulatory effect upon alkaline phosphatase levels in the presence of ascorbic acid and 6 - 
glycerophosphate (Table 7). In short-term cultures (up to 96 hours), dexamethasone (10-  ^
to 10 ®M) and other glucocorticoids have been shown to cause a transient stimulation of 
alkaline phosphatase expression followed by inhibition (Canalis, 1983b). However, 
Canalis (1983b) studied this aspect of osteoblastic behaviour in organ cultures of fetal rat 
calvaria. Organ cultures contain all the cell types associated with bone and also maintain 
the microenvironment Dexamethasone may be exerting a direct action upon preosteoblasts 
and osteoblasts, causing the initial increase in alkaline phosphatase activity. The cultures of 
isolated osteoblasts used in this study responded to dexamethasone with a sustained
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increase in alkaline phosphatase levels. However, organ cultures of calvaria will contain 
osteo-progenitors and the eventual decline of alkaline phosphatase may be explained by 
dexamethasone inhibiting progenitor differentiation and proliferation and consequently 
halting progression through the osteogenic lineage. Another glucocorticoid, cortisol, has 
been shown to affect bone growth by primarily inhibiting the proliferation of 
osteoprogenitors (Chyun et ah, 1984). Dexamethasone may also stimulate the progenitor 
cells in organ cultures to produce a factor inhibiting preosteoblast and osteoblast 
differentiation. So, even though osteoblast cultures are depleted in progenitors, 
dexamethasone would cause an overall stimulation of alkaline phosphatase in the absence 
of any inhibiting factor(s) produced by dexamethasone-induced stimulation of osteo­
progenitors.
Dexamethasone had no effect upon proliferation (Table 8 ). In other studies, the 
effects of dexamethasone upon proliferation have been varied, depending upon the age and 
type of culture and the species involved. Proliferation of rat osteoblasts is inhibited by 
dexamethasone in sparse and sub-confluent cultures (Chen et al., 1983; Chen and 
Feldman, 1979). There is no effect upon cultures of intermediate cell density and cultures 
treated at a post-confluent stage. However, dexamethasone stimulates proliferation in 
dense cultures. In organ cultures, there is no effect at 24 hours, but by 96 hours there is 
inhibition of proliferation (Canalis, 1983b). In chick periosteal explants, dexamethasone 
stimulates proliferation up to 6  days in culture (Tenenbaum and Heersche, 1985). 
Dexamethasone inhibits proliferation in cultures of mouse osteoblasts at all densities (Chen 
etaLy 1983).
The inhibition of proliferation seen in the cultures of mouse osteoblasts by Chen 
and colleagues (1983) cannot be directly compared with the lack of effect seen in this 
study. The incubation period was over 5 days and, perhaps more importantly, the culture 
medium lacked ascorbic acid and organic phosphate. In the absence of ascorbic acid, the 
proportion of alkaline phosphatase positive cells will be reduced and would therefore be a 
different cell population to that used in this study. Dexamethasone may exert differential
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effects upon alkaline phosphatase negative and positive cells, causing an overall inhibition 
in the experiments of Chen and colleagues and no effect in this study.
Dexamethasone caused a highly significant decrease in cell numbers at day 14 
(Table 13). As no inhibition was seen over the 14 day period as a whole (Table 8 ), this 
may represent a delayed decrease in proliferation due to inhibition of osteoprogenitor 
differentiation. Alkaline phosphatase activity is stimulated in osteoblasts cultured in the 
absence of ascorbic acid (Table 8 ), However, even though significant, the stimulation is 
slight and may be masked by the more intense stimulation caused by ascorbic acid.
iv) Effect of growth factors
a) Epidermal growth factor
EGF inhibits alkaline phosphatase activity in vitro (Canalis, 1983a; Kumegawa et 
al,y 1983; Yokota et aL, 1986). EGF has also been shown to stimulate proliferation in 
vitro (Kumegawa et a i,  1983; Raisz et a i, 1980; Yokota et a i, 1986). In this study, EGF 
was shown to have no effect upon proliferation and to inhibit alkaline phosphatase activity, 
although by day 14 the latter effect was no longer significant statistically (Figure 8  and 
Table 14). In vivo, EGF receptors have not been found on functional osteoblasts but they 
are present on osteoblast-like cells and undifferentiated cells (Martineau-Doizé et a i, 1988). 
As it is the undifferentiated cells that possess a high proliferative potential, their absence or 
scarcity in the osteoblast cultures would explain the lack of any apparent mitogenic action. 
However, action of EGF on proliferation may have been influenced by that of growth 
factors in fetal calf serum used as a media supplement.
b) Platelet-derived growth factor
PDGF has been shown to inhibit alkaline phosphatase activity in osteoblasts 
derived from neonatal rat calvaria (Schmid et a i, 1984). The media used contained 
ascorbic acid, and in this study it was found that PDGF inhibited alkaline phosphatase 
activity in the presence of ascorbic acid, but was stimulatory in the absence of ascorbic acid 
(Table 15). This indicates an inhibitory effect of PDGF upon cells stimulated by ascorbic
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acid to differentiate while itself providing a slight positive stimulus in relatively 
undifferentiated cells. As with EGF, no mitogenic action was found due to PDGF. In 
other studies, PDGF has has been shown to stimulate proliferation (Schmid et al., 1984; 
Canalis, 1981; Canalis and Lian, 1988).
3. Osteogenesis in vitro
The formation of bone in vitro is dependent upon the synthesis and secretion of 
bone-related proteins, predominantly type I collagen, and the organised deposition of 
mineral crystals characterised by the nucleating action of matrix vesicles or collagen fibrils 
and the formation of a mineralisation front. In vitro, osteogenesis occurs in discrete 
nodules, each of which is probably derived from the differentiation and proliferation of one 
cellular unit (Bellows and Aubin, 1989; Bellows et a i,  1986; Bhargava et aL, 1988; 
Ecarot-Charrier et al., 1983; Nefussi et a i, 1985).
i) Morphology
At confluence, the osteoblasts formed a layer of cuboidal cells (Figure 21) in a 
manner similar to that occurring in bone in vivo (Rodan and Rodan, 1984). After reaching 
confluence, the cultures formed multilayers of cells. Discrete patches of cells then 
developed into pronounced nodules (Figure 19a) which mineralised in the presence of 6 - 
glycerophosphate (Figure 19b). Osteogenic nodules in vitro have also been seen in 
cultures of neonatal mouse calvarial cells established by migration (Ecarot-Charrier et at., 
1983) and in cultures of fetal rat calvarial cells isolated enzymatically (Bellows et a l, 1986; 
Bhargava et a i, 1988; Nefussi et al., 1985). Cultures of bone marrow cells have also been 
shown to form osteogenic nodules (Maniatopoulos et al., 1988).
Scanning EM showed the nodules to be raised above the main surface of the culture 
and to be heavily calcified (Figure 9). X-ray emission analysis of the nodules (Figure 10) 
showed the elemental composition to be mainly phosphorous and calcium, indicating the 
probable presence of hydroxyapatite (Osdoby and Caplan, 1980; Bhargava et al., 1988; 
Maniatopoulos et al., 1988).
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Transmission EM showed the abundance of collagen in the extracellular space with 
the characteristic appearance of type I collagen: prominent transverse banding with a 
periodicity of approximately 62nm (Figure 14) (Piez, 1987), Type II collagen also 
presents periodic banding, but the fibrils are much thinner and the banding pattern is 
indistinct. Matrix vesicles were present amongst the collagen fibrils (Figure 13). In vivo 
matrix vesicles are closely associated with the onset of mineral deposition and may act as 
inducers of mineralisation (Anderson and Reynolds, 1973; Bonucci, 1987). These 
structures have previously been observed in areas of highly disorganised collagen fibres 
from cultures of bone cells from neonatal mice (Ecarot-Charrier et al., 1988). However, 
compared to cartilage matrix vesicles, those of bone are small, scarce and rapidly calcified 
(Anderson, 1989). Consequently, they are not often seen.
Mineralisation of the extracellular matrix was confined to the osteogenic nodules 
and was found in association with collagen fibrils (Figure 14). The deposition of mineral 
was very clearly intimately connected with the fibrils as nascent mineral spicules were 
deposited along the fibrils perpendicular to the banding pattern. This type of mineralisation 
is similar to that found in lamellar bone. Few matrix vesicles and initial mineral deposition 
associated with the collagen fibrils (Gehron Robey et a l,  1988).
Morphologically the events occuning within the osteogenic nodules very closely 
resemble bone formation in vivo. The process of mineralisation appears to be regulated as 
mineral is only seen in discrete patches in association with collagen fibrils. The 
arrangement of the collagen in some areas was very organised and was probably controlled 
by osteoblastic activity (Jones and Boyde, 1976). The regulation of matrix synthesis and 
mineralisation is ultimately controlled by osteoblasts, which in turn differentiate in vitro 
into osteocytes and become embedded within the mineralised matrix (Figure 16). They 
were situated within lacunae and exhibited extended processes, which in vivo would <
probably penetrate into canaliculi (Marks and Popoff, 1985).
The cultures of neonatal mouse osteoblasts can therefore be considered to be 
osteogenic and to provide an in vitro model of bone formation.
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ii) Effect of organic phosphate
6 -glycerophosphate has been shown to be necessary for the mineralisation of 
embryonic chick periostea in vitro (Tenenbaum, 1981). Quantification of the extent of 
mineralisation has shown a dose-dependent increase in calcium content with increasing 6 - 
glycerophosphate concentrations in both neonatal mouse osteoblasts (Table 17) and a clonal 
mouse osteoblast cell line, MC3T3-E1 (Kodama et al., 1986). The results of this study are 
therefore in complete agreement with the published work, validating the use of the 
colourimetric method.
iii) Effect of seeding density
The concept of the CFU-O implies an increased incidence of osteogenesis with 
increasing cell density. Cultures of fetal rat calvarial osteoblasts at low densities form 
calcified osteogenic nodules in direct proportion to the number of cells seeded (Bellows et 
al., 1986; Bellows and Aubin, 1989). At higher densities, neonatal mouse osteoblasts 
produce a matrix which is increasingly calcified with increasing cell number at seeding 
(Table 18). However, at extremely high density, the amount of calcium deposited 
decreases, which may represent a general toxic effect due to accumulation of metabolic 
products, despite frequent media changes.
iv) Effect of hormones
a) Insulin
Insulin stimulates collagen synthesis in organ cultures of fetal rat calvaria (Canalis, 
1983a). In cultures of neonatal mouse osteoblasts, insulin caused a significant increase in 
the extent of calcification (Figure 20), presumably this is secondary to the increased 
stimulation of collagen synthesis. In the absence of ascorbic acid, collagen synthesis is 
abnormal. However, under this condition, insulin at 5000ng/ml encouraged the formation 
of a calcified matrix, even though minimally.
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b) Dexamethasone
Dexamethasone has been shown to cause a transient stimulation, followed by 
inhibition, of bone formation, alkaline phosphatase levels, proliferation and collagen 
synthesis in organ cultures (Canalis, 1983b; McCulloch and Tenenbaum, 1986). 
However, dexamethasone has also been shown to stimulate osteogenic nodule formation in 
cultures of isolated fetal rat osteoblasts (Bellows et al., 1986; Bellows et al., 1987). In this 
study, dexamethasone caused a significant decrease in the extent of calcification in cultures 
of neonatal mouse osteoblasts (Table 16).
These paradoxical effects are probably due to differences between species and the 
responsiveness of osteoprogenitors and more differentiated cells. At approximately the 
same plating density (3.0 to 4.0 x 10  ^cells/cm^) as that used by Bellows and colleagues 
(1986) dexamethasone stimulated rat osteoblastic proliferation (Chen et al., 1983). In 
cultures of rat cells, the stimulation of osteogenic nodule formation by dexamethasone is 
probably due to the increased cell number. The decrease in calcification (Table 16) may be 
due to a reduced volume of matrix following a highly significant decrease in cell number 
(Table 13) by day 14 of culture with dexamethasone.
v) Effect of growth factors
a) Epidermal growth factor
Short-term exposure (up to 4 days) to EGF causes a highly significant increase in 
nodule formation by rat calvarial cells (Antosz et al., 1987). This may be due to the 
mitogenic effect of EGF, resulting in the formation of more nodule precursors without a 
concurrent committment to proliferation. Long-term exposure to EGF causes a highly 
significant decrease in the extent of calcification (Figure 21) and in the number of nodules 
(Antosz et al., 1987). EGF has also been shown to selectively inhibit collagen synthesis 
(Canalis, 1983a; Canalis and Raisz, 1979; Hiramatsu et a l, 1982; Kumegawa et al., 
1983).
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In organ cultures of fetal rat radii and ulnae, EOF causes a significant increase in 
resorption, as measured by the release of "^ ^Ca from pre-labeled bones (Raisz et aL, 1980). 
It would seem, therefore, that EGF could have a profound role in bone remodeling; 
stimulating resorption and inhibiting formation.
b) Platelet-derived growth factor
At 24 hours, PDGF has been shown to stimulate non-coUagenous protein synthesis 
in organ cultures of fetal rat calvaria (Canalis, 1981; Canalis and Lian, 1988). At 60ng/ml 
(but not l(X)ng/ml) PDGF increased collagen synthesis, but by 96 hours the effect was 
inhibitory. The inhibition of matrix protein synthesis is probably the cause of the lack of 
calcification seen in cultures of neonatal mouse osteoblasts (pg 98).
4. Osteoblastic products in vitro
i) Haemopoietic cell growth factors
The importance of stromal elements during haemopoietic differentiation is indicated 
by the events occurring following marrow transplantation. Haemopoiesis by host cells is 
initiated by following osteogenic differentiation of the transplant (Friedenstein, 1976). 
Furthermore, the type of haemopoiesis is dependent upon the source of the donor marrow 
(Patt et al.y 1982). It has been known for some time that there is a non-haemopoietic 
compartment in the marrow cavity capable of producing colony stimulating factors (CSFs) 
(Chan and Metcalf, 1972). Marrow stromal cells lines have been shown to produce 
monocyte/macrophage colony stimulating factor (M-CSF) in vitro (Lanotte et g/., 1982). 
M-CSF acts upon granulocyte/macrophage colony forming cells (GM-CFC) in vitro 
resulting in the formation of monocyte/macrophage colonies. It has also been shown that 
glycosaminoglycans of the extracellular matrix of the marrow stroma can bind CSF and 
may act by;
i) locally concentrating tissue-specific growth factors,
ii) releasing active factors from this pool (Gordon et al., 1987).
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The stromal cells of bone have also been shown to produce haemopoietic growth 
factors. Primary cultures of neonatal mouse calvarial osteoblasts secrete 
granulocyte/macrophage CSF (GM-CSF), both constitutively (Figure 22) and following 
stimulation of monolayers by PTH and lipopolysaccharide (LPS) (Horowitz et aL, 1989). 
The increase in CSF production with time in culture (Figure 11) shows that the source is 
osteoblastic cells rather than contaminating marrow-derived cells. The osteoblastic origin 
of CSF has also been shown by the release of CSF from clonal osteoblastic cells lines, 
MC3T3-E1 and ROS, and neonatal mouse calvaria (Elford et a i,  1987; Felix et al., 1988; 
Felix et al., 1989; Shiina-Ishimi étal., 1986; W eiret a/., 1989).
Media conditioned by MC3T3-E1 cells contained CSF and the synthesis of this 
factor increased with time in culture and was stimulated by interleukin 1 , tumour necrosis 
factor a , LPS and the combined action of TGFB and EGF (Elford et al., 1987; Felix et al., 
1989; Shiina-Ishimi et al., 1986). ROS cells also secreted GM-CSF both constitutively 
and following stimulation by PTH and LPS (Weir et al., 1989). The change with time of 
the type of colony formed suggests that osteoblasts may secrete both M-CSF and GM-CSF 
(Table 19).
Osteoblastic CSFs may play a role in the control of differentiation and proliferation 
of osteoclastic precursors. Co-culture of rat fetal bone rudiments with purified populations 
of G-CFC and GM-C!FC resulted in a highly significant increase in the number of 
osteoclasts present within the rudiment. However, co-culture with M-CFC had no effect 
(Schneider and Relfson, 1988). It is possible, that osteoclasts and granulocytes share a 
common lineage and osteoclast formation could consequently be sensitive to the action of 
osteoblast CSFs. GM-CSF would encourage osteoclast formation whereas M-CSF would 
act in opposition, biasing GM-CFC differentiation towards monocyte/macrophage 
phenotypes, ie it would inhibit osteoclast formation, M-CSF has also been found to be a 
potent inhibitor of resorption by isolated osteoclasts incubated on bone slices (Hattersley et 
al., 1988). In the same study, GM-CSF had no effect upon bone resorption.
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aTherefore, the stromal cells of bone, as well as of the marrow cavity, synthesise 
haemopoietic cell growth factors involved in the regulation of GM-CFC differentiation.
Via this mechanism, it is likely that osteoblasts can contribute to the regulation of osteoclast 
formation.
ii) Effect on mesenchymal cells
Balb/c 3T3 cell lines are derived from cultures of minced Balb/c mouse embryos 
(Aaronson and Todaro, 1968). In vitro, these lines are capable of expressing a range of 
differentiated phenotypes and have been regarded as muMpotent mesenchymal stem cells 
(Boone and Scott, 1980; Krawisz et al,, 1981; Sparks and Scott, 1986; Sparks et aL,
1986). Untransformed cells implanted in vivo as monolayers grown on plastic plates form %
undifferentiated sarcomas with differentiated foci of chondrocytes, fibroblasts and capillary 
pericytes (Boone and Scott, 1980). Suspensions of spontaneously transformed cells 
implanted sub-cutaneously form tumours exhibiting a range of morphologies, including 
myoblastic differentiation (Rubin et aL, 1985). The range of stromal phenotypes expressed 
by differentiated Balb/c 3T3 cell lines, in vivo and in vitro, raised the possibility of;
i) the potential of osteogenic differentiation, and
ii) a response to factor(s) produced by osteogenic cultures.
In the system used there was no discernible osteogenic differentiation of Balb/c 3T3 
cells. The expression of alkaline phosphatase was minimal and in the presence of B- 
glycerophosphate there was no deposition of mineral crystals (Table 19). Addition of 
concentrated osteoblast conditioned medium caused an inhibition of proliferation at low 
concentrations and a stimulation at high concentrations. The mitogenic activity may well be 
due to the presence of a bone cell-derived growth factor(s). However, without further 
investigations it is not possible to determine the cellular source or whether the activity is 
general or specific for mesenchymal cells.
I
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The lack of osteogenic differentiation, both in the absence and presence of the 
osteoblast conditioned medium, may reflect inadequacies in the system employed. 
However, a negative result such as this can not make the distinction between faults inherent 
in the experiment and a genuine lack of osteogenic potential in the 3T3 cells. Indeed, if the 
osteogenic and chondrogenic lineages do share a common progenitor (Figure 2) then the 
expression of the chondrogenic phenotype may be an implicit indication of osteogenic 
potential.
However, it should be borne in mind that the pre-neoplasia and metaplasia exhibited 
by Balb/c 3T3 cell lines shows a lesser degree of regulation of differentiation and 
proliferation than that of normal cells. This is shown by the ability of 3T3 cells to first 
follow adipocytic differentiation and then still be capable of dedifferentiation and 
transdifferentiation (metaplasia) to the macrophage phenotype (Sparks et aL, 1986).
In summary, osteogenic differentiation can occur in vitro in cells derived from 
neonatal mouse calvaria. Quantification of parameters associated with the differentiated 
phenotype, alkaline phosphatase expression and calcium deposition, can provide 
information concerning the regulation and pattern of differentiation. Osteogenic cultures 
secrete factors into the media which stimulate differentiation of haemopoietic cells and the 
proliferation of mesenchymal cells. However, there is still a great deal to be understood 
concerning the interplay between bone cells, marrow stromal cells and haemopoietic cells. 
Although the existence, in the adult mammal, of a common stem cell is very unlikely 
there is a high degree of dependence between these systems in terms of cellular origins and 
control of differentiation and proliferation.
Future work on the differentiation of bone cells in vitro should concentrate on, not 
only the production of haemopoietic cell growth factors by osteoblasts, but also the role of 
marrow cells in stromal differentiation. If the stromal stem cell is located within the 
marrow cavity then the haemopoietic cells are ideally situated to exert control over 
differentiation and proliferation. In vitro, this can be studied using, for instance, long term
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bone marrow culture conditioned medium and also co-culture of haemopoietic cells with |
osteoblasts and the mesenchymal stem cell line, Balb/c 3T3.
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Figure 9. (Mag. x 4(X))
Transmission electron micrograph of the surface of a 14 day 
old primary culture of neonatal mouse calvarial osteoblasts showing 
an osteogenic nodule (N). A speckled image of the X-ray 
em m ission of the K a  o f calcium was overlaid, showing the 
localisation of calcium to the nodule.
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F igure 10.
A  p lo t o f  the X -ray  e m m iss io n  a n a ly s is  o f  a m in era lised  
o ste o g e n ic  nodule. There are prom inent peaks for phosphorous (P) 
and ca lc iu m  (K a ) , w ith  sm all peaks for so d iu m  (N A ), su lphur (S )  
and ca lc iu m  (K 6).
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F igure 11. (M ag. x  3 0 ,7 0 0 )
Transm ission electron micrograph from  a 7 day o ld  culture.
F igure 12, (M ag, x  2 8 ,1 7 0 )
Transm ission electron  micrograph from  a 10 day o ld  culture.
T he cultures have started to form  m ultilayers o f  c e lls . T he  
cy to p la sm ic  organ elles are characteristic o f  c e lls  in v o lv ed  in v o lv e d  
in  a c t iv e  p ro te in  sy n th e s is ;  m ito ch o n d r ia  (M C ) and  ro u g h  
en d op lasm ic  reticu lum  (R E R ). T he extracellu lar sp aces  con ta in s  
co llagen  fibrils in transverse (T S) and longitudinal section  (L S).
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Figure 13. (Mag. x 42,650)
Transmission electron micrograph from a 10 day old culture. 
The extracellular space contains abundant collagen fibrils in 
transverse (TS) and longitudinal section (LS). The collagen fibrils 
appear to be randomly arranged and are interspersed with matrix 
vesicles (MV).
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Figure 14. (M ag. x  56,350)
Transmission electron micrograph from a 14 day old  culture. 
M ineral (M ) has been deposited on  a fram ework provided by the 
collagen fibrils (C). Spicules (S) o f  mineral are extending along the 
fibrils and lie  parallel to the m ain axis o f  the fibril. Transverse 
banding (B) with a periodicity o f  approximately 62nm  is apparent on  
the fibrils.
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Figure 15. (M ag. x  67 ,050)
Transm ission electron micrograph from a 14 day old  culture. 
T he extracellu lar space has been  filled  w ith m ineral (M ). The  
osteob lasts is  still capable o f  protein synthesis, as show n by the 
presence o f  m itochondria (M C) and rough endoplasm ic reticulum  
(R E R ). B etw een  the c e ll and the m ass o f  m ineral lie s  an 
unm ineralised seam  o f  osteoid (O).
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Figure 16. (M ag. x  10,820)
Transm ission electron micrograph from a 14 day old  culture. 
A n osteo cy te  (O C ) has b eco m e com pletely  surrounded by m ineral 
(M ). A n unm ineralised seam  o f  osteoid  (O) is apparent, separating  
the c e ll from  the m ineral. T h e ce ll is  extend ing p ro cesses  (P) 
towards the m ineral, one o f  w hich  is lying in a canaliculum .
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Figure 17. (Mag. x 14,250)
Transmission electron micrograph from a 14 day old cuitu 
A rounded cell lying on the surface of a nodule. The cytopla; 
contains mitochondria (MC) and some rough endoplasmic reticuli 
(RER).
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Figure 18. (Mag. x 140)
Phase contrast light micrograph o f  a culture o f 2  to 3 day old  
prim ary osteob lasts. The ce lls  have form ed  a m onolayer o f  
polygonal cells.
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F igure 19a. (M ag. x  160)
L ight m icrograph o f  o steob lasts cultured  w ith ascorb ic acid  
and w ithout B -glycerophosphate. O steo g en ic  nodules h ave form ed  
(N ). H o w e v e r , th ese  are u n m in era lised  due to the lack  o f  
phosphate.
F igure 19b. (M ag. x  160)
L ight m icrograph o f  o steob lasts cultured w ith  ascorb ic acid  
and B-glycerophosphate. A n  o steogen ic  n od u le  (N ) has form ed and  
has m ineralised . In so lu b le  ca lc iu m  is  sh o w n  by the p resen ce  o f  
b lack  deposits o f  silver.
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